sundri
low
molecular
mass
nucleotid
addit
cyclic
mononucleotid
cyclic
amp
camp
cyclic
gmp
describ
pursu
fascin
biolog
properti
instanc
guanosin
magic
spot
nucleotid
establish
intracellular
messeng
influenc
transcript
rate
variou
gene
mediat
stringent
respons
esciretichia
coli
gallant
diadenosin
pr
origin
describ
zamecnik
et
al
back
reaction
lysyltrna
synthetas
establish
competit
inhibitor
platelet
aggreg
analogu
pursu
antithrombot
agent
chan
et
al
nicotin
acid
adenin
dinucleotid
phosphat
adpribos
cyclic
adpribos
found
regul
calcium
signal
genazzani
galion
review
encompass
uniqu
group
low
molecular
mass
molecul
refer
fig
l
repres
pp
interest
field
attest
volum
public
deal
excess
groundwork
discoveri
laid
effort
varieti
laboratori
tabl
work
led
classic
investig
kerr
brown
describ
exact
chemic
natur
paper
kerr
brown
requir
read
student
enter
field
nucleic
acid
chemistri
biochemistri
eleg
applic
basic
chemic
enzymat
principl
structur
elucid
although
chemic
structur
describ
nearli
two
decad
ago
recent
key
enzym
action
rnase
l
clone
final
purifi
homogen
tabl
much
accomplish
area
sinc
last
time
one
us
coauthor
review
system
johnston
torrenc
possibl
review
aspect
doublestrand
rna
dsrna
lengyel
interferon
ifn
induc
inhibit
viral
replic
present
effort
attempt
consolid
salient
find
featur
system
alon
fig
uniqu
natur
fig
impetu
host
public
detail
virtual
everi
conceiv
chemic
approach
molecul
tabl
quit
number
report
synthes
stop
short
provid
key
di
triphosph
moieti
requir
biolog
activ
tabl
howev
latter
key
transform
effect
appropri
protect
oligonucleotid
substrat
use
varieti
approach
tabl
applic
chemistri
other
led
consider
formulari
analogu
modif
ribos
moieti
base
phosphat
backbon
residu
tabl
addit
respect
number
ligand
alter
ad
termini
molecul
tabl
also
ligat
normal
linkag
nucleic
acid
rnaregul
nucleotidyl
transferas
occurr
synthetas
activ
demonstr
present
larg
varieti
mammalian
speci
includ
mous
rabbit
dog
guinea
pig
hamster
pig
monkey
cow
human
also
detect
virus
reptil
sever
avian
speci
includ
chicken
tabl
drosoph
amphibian
yeast
slime
mold
bacteria
howev
shown
possess
synthetas
activ
stark
et
al
cayley
et
al
howev
synthetas
recent
report
present
marin
spong
geodia
cydonium
base
poli
poli
c
bind
format
western
blot
antibodi
rat
kda
synthetas
kuusksalu
et
al
although
synthetas
identifi
plant
cayley
et
al
viru
resist
achiev
clone
rat
cdna
synthetas
follow
transform
tobacco
potato
truve
et
al
truve
et
al
synthetas
activ
found
larg
number
human
cell
type
basal
level
vari
greatli
activ
found
nuclei
cytoplasm
nilsen
et
al
human
diploid
fibroblast
contain
low
level
synthetas
stark
et
al
namalva
johnston
et
al
hela
kbalb
cell
meur
et
al
express
high
level
absenc
ifn
induct
enzym
occur
high
level
human
peripher
blood
cell
bruchelt
et
al
human
umbil
cord
blood
mononuclear
cell
william
read
homo
sapien
male
found
higher
concentr
enzym
polymorphonuclear
blood
cell
pmbc
miel
et
monocyt
separ
densiti
gradient
centrifug
greater
synthetas
level
lymphocyt
b
lymphocyt
separ
lymphocyt
fluorescenceactiv
cell
sort
higher
level
enzym
buffetjanvress
et
al
synthetas
also
present
serum
plasma
mice
krishnan
baglioni
human
bruchelt
et
al
rusconi
et
al
clinic
use
monitor
ifn
therapi
discuss
follow
section
import
induc
synthetas
ifn
degre
time
cours
induct
depend
dose
type
ifn
length
exposur
cell
type
extent
induct
observ
gener
severalfold
sever
hundredfold
although
remark
induct
report
chick
embryo
cell
ball
note
mani
induct
studi
base
enzym
activ
level
oppos
measur
protein
l
linear
relationship
establish
number
investig
demonstr
differenti
induct
type
versu
type
ii
ifn
wallach
et
al
found
lower
level
synthetas
human
fibroblast
ramo
cell
treatment
ifni
compar
mous
cell
howev
synthetas
level
similar
ifnp
treatment
hovanessian
et
al
ifn
shown
induc
lower
synthetas
level
monocyt
line
myelocyt
line
human
periton
macrophag
well
viva
cleavag
specif
rnase
l
establish
wreschner
et
al
floydsmith
et
al
identif
four
differ
form
synthetas
human
cell
purif
synthetas
chebath
et
al
ball
white
well
et
al
dougherti
et
al
ball
yang
et
al
mari
et
al
ilson
et
al
dominantneg
mutant
rnase
l
bound
effici
lack
nucleas
activ
express
murin
cell
prevent
antiemcv
effect
ifn
hassel
et
al
activ
kda
form
sythetas
found
bound
viral
rna
ifntreat
emcvinfect
hela
cell
clone
human
mous
rnase
l
introduct
gribaudo
et
nl
zhou
et
al
hassel
et
al
torrenc
et
al
total
peripher
blood
mononuclear
cell
pbmc
witt
et
al
ifncx
p
shown
bind
differ
class
cell
surfac
receptor
type
ifn
type
ii
branca
sinc
type
cell
determin
respect
receptor
concentr
k
transcript
regul
synthetas
close
tie
receptor
occup
hannigan
surpris
induct
event
would
differ
rween
two
class
ifn
hela
cell
treat
enp
lag
rapid
rise
synthetas
level
peak
remain
constant
hr
reflect
de
nova
protein
synthesi
time
cours
induct
synthetas
ifni
found
slower
found
type
ifn
hela
cell
baglioni
maroney
number
studi
specif
examin
kinet
viva
induct
synthetas
lodemann
et
al
found
dose
x
ukg
ifna
synthetas
measur
pbmc
peak
hr
iv
rout
superior
im
inject
anoth
trial
ena
rang
induct
synthetas
found
howev
extent
durat
synthetas
respons
function
dose
rout
number
inject
merritt
et
al
dose
x
enp
sc
synthetas
atp
amp
level
peak
hr
pbmc
lysat
hr
serum
dose
x
u
ifn
caus
smaller
increas
synthetas
bruchelt
et
al
trial
enpi
combin
togeth
continu
infus
found
doselimit
toxic
x
u
mg
ifn
consist
refractori
headach
fever
hepat
toxic
schiller
et
al
also
well
establish
type
ifn
induc
transcript
synthetas
gene
presenc
cycloheximid
unlik
type
ii
ifn
gener
dianzani
et
al
faltynek
et
al
gribaudo
et
al
impli
synthetas
induc
primari
respons
treatment
cell
type
ifn
sinc
new
protein
synthesi
requir
howev
new
protein
synthesi
requir
induct
synthetas
ifni
earli
evid
superinduct
synthetas
chick
embryo
fibroblast
stimul
homolog
ifn
synthetas
level
peak
hr
ifn
remov
addit
cycloheximid
could
delay
decay
west
ball
restor
lab
et
al
synthetas
activ
four
isoform
ifn
describ
chebath
et
al
hovanessian
et
al
variou
isoform
induc
differenti
given
ifn
subtyp
melanoma
cell
hr
ikehara
et
al
ikehara
et
al
pocl
po
oet
ikehara
et
al
mesitylen
sulfonyl
triazolid
shimidzu
et
al
hayakawa
et
al
b
chattopadhyaya
jone
rees
charubala
pfleider
charubala
pfleider
engel
krahmer
gioeli
et
al
tri
phosphin
n
protect
necessari
triester
approach
reaction
phosphorochlorid
mg
alkoxid
protect
nucleosid
n
protect
triisopropylbenzen
sulfonyl
nitrotriazolid
quinolin
ssulfonyl
chlorid
triester
approach
triisopropylbenzen
sulfonylnitroimidazolid
use
sawai
et
al
sawai
et
al
catalysi
adenosin
pp
catalysi
phosphoromorpholinochlorid
use
introduc
monomer
synthon
follow
zn
deblock
tribromoethyl
moieti
convers
result
monophosph
acid
hydrolysi
trinbutylammonium
phosphat
bi
trinbutylammonium
diphosph
oligomer
onitrobenzoyl
gave
directli
obtain
intermedi
phosphoroimidazolid
jone
rees
reaction
fulli
protect
except
trinucleotid
smethylphosphorochloridothio
yield
deblock
react
excess
tetra
trinbutylammonium
pyrophosph
sawai
et
al
pb
catalyz
polymer
reaction
product
convert
phosphoroimidazolid
bi
trinbutylammonium
diphosph
ligat
nucleosid
mononucleosid
dinucleotid
provid
oligonucleotid
termin
could
convert
acid
hydrolysi
triphosph
reaction
either
bi
trinbutylammonium
phosphat
bi
trinbutylammonium
diphosph
respect
imai
torrenc
complet
protect
product
triester
synthesi
convert
free
mmt
remov
phosphoryl
bi
phosphorochlorid
follow
oxid
yield
convert
phosphoroimidazolid
reaction
bi
trinbutylammonium
diphosph
approach
advantag
critic
incorpor
mask
form
chain
extens
need
separ
need
separ
obviat
incorpor
final
monophosph
synthet
procedur
result
mixtur
serv
protect
group
bond
format
also
activ
precursor
desir
mono
di
triphosph
mmt
pmonomethoxytrityl
treatment
uml
rifnora
isoform
induc
twice
extent
contrast
rifni
uml
induc
isoform
equal
rosenblum
et
al
induct
isoform
also
studi
daudi
fibroblast
colon
adenocarcinoma
cell
vitro
viva
witt
et
al
b
signific
differ
induct
cell
type
ifnp
ifni
addit
differenti
induct
occur
pbmc
lysat
taken
normal
donor
cultur
ifn
vitro
cancer
patient
treat
np
isoform
also
present
speci
shimizu
et
al
synthetas
level
alway
correl
extent
antivir
state
lewi
inhibit
encephalomyocard
viru
emcv
replic
seem
correl
synthetas
induct
likewis
mengoviru
vaccinia
replic
inhibit
character
high
synthetas
level
chebath
et
al
grun
et
al
resist
vesicular
stomat
viru
vsv
replic
howev
occur
absenc
detect
increas
synthetas
activ
hovanessian
et
al
meur
et
al
inhibit
influenza
viru
herp
simplex
viru
herp
delta
viru
replic
seem
result
synthetas
activ
de
benedetti
et
al
taylor
et
al
mcnair
et
al
suppress
synthetas
induct
persist
infect
mump
viru
also
document
fuj
ii
et
al
ifn
confer
antivir
activ
heterolog
cell
examin
synthetas
level
also
found
elev
thu
chicken
ifn
confer
resist
quail
cell
rais
synthetas
level
fulton
et
al
human
ifnaa
show
antivir
synthetas
induc
activ
mdbk
wish
cell
neither
activ
cell
enhanc
induct
synthetas
may
play
part
welldescrib
potenti
ifn
action
febril
modif
glycon
moieti
termin
ribos
oxid
io
provid
dialdehyd
coupl
palaninetyrosin
dipeptid
modif
lmethoxyhexadecyliden
adenosin
core
trimer
analogu
modifi
nucleosid
includ
adenin
adenin
adenin
tyrosin
methyl
ester
acycl
analogu
hoch
ch
oh
och
ade
chch
op
oh
repeat
unit
trinucleotid
analogu
adenylyl
adenosin
hexadecanrylamino
adenylyl
adenosin
acycl
modif
adenylyl
hydroxyethoxi
methyi
adenin
hexadecanoylamino
adenylyl
adenylyl
hydroxyethoxi
methyi
adenin
core
analogu
substitut
tbdm
group
tbdm
adduct
consist
cvialent
conjug
termini
analogu
vitamin
dl
e
lipid
ideoxyadenylyl
hydroxyalkyl
adenin
variat
number
methylen
hydroxyalkyladenin
chain
sequencespecif
analogu
pp
den
hartog
et
al
kinjo
et
al
gosselin
imbach
sawai
torrenc
et
ai
lesiak
et
al
engel
imai
er
al
pressova
smrt
bayard
et
al
herdewijn
et
al
kvasyuk
et
al
mikhailov
pfleider
kvasyuk
et
al
schirmeist
pfleider
wasner
et
al
charubala
pfleider
homdler
pfleider
wasner
et
al
sawai
et
al
charubala
pfleider
nyila
et
al
mikhailov
et
al
torrenc
et
al
charubala
et
al
analogu
refer
yphosphorothio
p
ydifluoromethylenephosphon
analogu
tetram
also
poli
llysin
conjug
yphosphorothio
analogu
obtain
enzymat
synthesi
apoli
llysin
coupl
vi
period
oxid
follow
schiff
base
format
cyanoborohydrid
reduct
analogu
includ
n
n
n
rc
rg
ru
dt
dc
dg
da
enzymat
ch
modif
backbon
moieti
analogu
rp
pthioadenylyl
adenosin
sp
pthioadenylyl
adenosin
rp
pthioadenylyl
rp
pthioadenylyl
adenosin
rp
pthioadenylyl
sp
pthioadenylyl
adenosin
sp
pthioadenylyl
rp
pthioadenylyl
adenosin
sp
pthioadenylyl
sp
pthioadenylyl
adenosin
also
diasteromer
tetram
adenylyl
rp
pthioadenylyl
adenosin
adenylyl
sp
adenosin
rp
rp
deoxyadenosin
bisbal
et
al
bayard
et
al
imai
torrenc
drocourt
et
al
bayard
et
al
sawai
et
al
nyila
et
al
kovac
et
al
kwiatkowski
et
al
kwiatkowski
et
al
sawai
et
al
pfleider
et
al
visser
et
al
lesiak
er
al
den
hartog
et
al
charubala
pfleider
kariko
ludwig
watl
et
al
beigelman
et
al
charubala
pfleider
charubala
pfleider
charubala
pfleider
also
battistini
et
al
also
shimazu
et
al
also
nelson
et
al
charubala
et
al
de
vroom
et
al
sobol
et
al
modif
aglycon
moieti
inosin
analogu
tetrarr
r
r
deoxyuridin
acyclovir
xylofuranosyl
analogu
core
trimer
analogu
contain
adenin
adenin
analogu
charubala
pfleider
torrenc
et
al
torrenc
et
al
kitad
et
al
torrenc
et
al
k
lesiak
p
f
torrenc
unpublish
observ
jamoul
et
al
jamoul
torrenc
kvasyuk
et
al
lesiak
torrenc
yoshida
takaku
b
lesiak
torrenc
torrenc
et
al
kitad
et
al
yoshida
takaku
herdewijn
et
al
herdewijn
et
al
suhadolnik
et
al
suhadolnik
et
al
charubala
et
al
tbdm
tbutyldimethylsilyl
temperatur
hyperthermia
induc
synthetas
mdbk
cell
also
releas
heat
shockinduc
factor
hsif
turn
could
induc
synthetas
human
wish
cell
chousterman
et
al
hsif
sinc
shown
atyp
bovin
ifn
gachet
et
al
ifnmedi
antivir
effect
enhanc
lofold
type
ifntreat
wish
cell
cultur
c
associ
increas
synthetas
chang
wu
stabil
assay
show
mrna
halflif
select
extend
hr
although
halfliv
poli
rna
pactin
mrna
remain
unchang
glucocorticoid
concentr
capabl
inhibit
dna
synthesi
cell
divis
induc
synthetas
daudi
raji
cell
krishnan
baglioni
cortexolon
inhibit
glucocorticoid
induct
inhibit
synthetas
induct
ifn
synthetas
activ
also
increas
chick
oviduct
estrogen
withdraw
stark
et
al
antiestrogen
tamoxifen
level
growth
inhibitori
increas
synthetas
rnase
l
level
cell
line
estrogen
receptor
posit
one
receptor
neg
evsat
viano
et
al
number
autocrin
growth
factor
induc
synthetas
alon
combin
variou
ifn
addit
synthetaseinduc
effect
ifn
transform
growth
factor
tgf
ol
observ
cell
wietzerbin
et
al
although
question
whether
tgf
r
could
induc
synthetas
absenc
ifn
address
kumar
mendelsohn
epiderm
growth
factorurogastron
caus
induct
synthetas
human
fibroblast
revers
antiifnp
antibodi
lin
et
al
plateletderiv
growth
factor
pdgf
induc
synthetas
murin
balbc
cell
presenc
monoor
polyclon
antibodi
murin
ifnp
et
al
tumor
necrosi
factora
combin
either
ifnp
ifni
exhibit
signific
synerg
regard
synthetas
induct
mestan
et
al
wietzerbin
et
al
nerv
growth
factor
ngf
induc
synthetas
rat
pheochromocytoma
cell
line
basi
effect
unclear
saarma
et
al
ever
sinc
find
treatment
daudi
cell
ifna
ifnp
caus
transient
increas
level
diacylglycerol
yap
et
al
signific
interest
contribut
protein
kinas
c
pkc
induct
synthetas
investig
found
pkc
activ
tpa
potenti
action
ifn
daudi
hela
cell
pkc
inhibitor
staurosporin
inhibit
synthetas
induct
downregul
pkc
tpa
decreas
synthetas
induct
faltynek
et
al
raber
et
al
chang
et
al
percario
et
al
contrari
other
observ
decreas
synthetas
activ
shortterm
treatment
tpa
yan
et
al
addit
research
need
done
clarifi
import
pkc
induct
synthetas
ifn
vasoact
intestin
peptid
shown
induc
synthetas
glial
cell
cell
neuron
induct
synthetas
preced
synthesi
heat
shock
protein
hsp
abolish
treatment
antiifnap
cyclic
amp
also
induc
synthetas
mrna
transcript
level
itk
et
al
although
site
synthetas
region
analog
camprespons
element
tgacgtca
sever
potenti
transcript
bind
factor
site
exist
itk
interleukin
il
also
found
exhibit
synerg
type
ifn
ml
cell
possibl
induc
dna
bind
factor
cohen
et
al
ml
cell
induc
differ
synthetas
isozym
ifn
includ
one
cellsurfac
associ
murin
ifncxp
antibodi
complet
abolish
synthetas
induct
mediat
gothelf
et
al
number
drug
chemic
report
increas
synthetas
activ
tabl
whether
intermedi
product
ifn
respons
induct
usual
address
agent
found
decreas
synthetas
induct
includ
gangliosid
krishnamurti
et
al
arachidon
acid
analogu
menon
et
al
glucos
onishi
et
al
concanavalin
faltynek
et
al
sinc
level
synthetas
mrna
decreas
apoptosi
synthetas
protein
surmis
play
direct
role
cell
death
product
howev
recent
experi
suggest
role
system
apoptosi
castelli
et
al
see
section
consider
evid
document
neg
growth
regulatori
effect
ifn
whether
system
play
direct
role
product
follow
rnase
lmediat
cleavag
cellular
mrna
somewhat
less
clear
synthetas
activ
found
low
normal
prolifer
dipioid
syrian
hamster
cell
higher
densityarrest
cell
uniformli
low
neoplast
transform
deriv
cell
absenc
autocrin
ifn
product
hassel
ts
similar
result
obtain
bscl
line
synthetas
level
greatest
quiescent
cell
also
case
namalva
cell
synthetas
level
highest
serumstarv
condit
krishnan
baglioni
also
cell
synthetas
level
highest
west
ball
sekellick
et
al
lab
et
al
oikarinen
stark
et
al
kuhr
et
al
birnbaum
et
al
sokawa
sokawa
fulton
et
al
akagi
et
al
schmitt
et
al
short
et
nl
shimizu
sokawa
dandrea
et
al
short
et
nl
bosworth
et
al
etiennesmeken
et
al
rice
et
al
bannai
et
al
bannai
krishnan
baglioni
shimizu
sokawa
wang
wu
hassel
ts
suhadolnik
et
al
li
et
al
kariko
et
al
cayley
et
al
wallach
revel
confluenc
jacobsen
et
al
stabl
transfect
human
synthetas
cell
associ
emcv
resist
also
reduc
rate
cellular
prolifer
rysiecki
et
al
level
synthetas
cell
cycl
examin
use
mous
embryo
tertiari
fibroblast
progress
synchron
cell
cycl
determin
fluorescenceactiv
cell
sort
synthetas
level
found
low
quiescent
cultur
well
gl
earli
rose
lofold
late
decreas
sharpli
similar
though
quantit
lower
pattern
found
rnase
l
induct
synthetas
preced
antiprolif
effect
ifn
moloney
murin
sarcoma
viru
msv
transform
nih
cell
salzberg
et
al
treatment
cell
ifn
result
growth
inhibit
kinet
correl
signific
increas
pbmc
viwo
administr
litton
et
al
tyrosin
kinas
inhibitor
melanoma
cell
ralph
et
al
retino
acid
cell
wish
namalva
korutla
bourgead
besacon
indomethacin
serum
tiiuo
administr
andreon
et
al
bile
acid
imiquimod
human
pbmc
pbmc
viva
administr
podevin
et
al
witt
et
al
ethanol
mdbk
cell
chelbialix
chousterman
dimethyl
sulfoxid
theophyllin
cell
cell
schwartz
nilson
itk
et
al
b
synthetas
isozym
kumar
mendelsohn
synthetas
isoenzym
induc
day
isozym
induc
late
remain
high
day
treatment
ifn
shown
potenti
respons
tcell
mitogen
induc
antivir
state
landolfo
et
al
howev
studi
ifncx
ifni
induc
increas
synthetas
human
ifncx
shown
caus
blast
cytoreduct
peripher
blood
marrow
juvenil
acut
myelogen
leukemia
patient
concert
increas
synthetas
level
freedman
et
al
salzberg
et
al
found
ifn
treatment
msvtransform
nih
fibroblast
result
decreas
rate
cell
growth
protein
synthesi
clone
effici
parallel
iofold
rise
synthetas
level
recoveri
occur
level
ifn
treatment
significantli
decreas
synthetas
level
drop
also
antivir
growth
inhibitori
effect
seem
dissoci
genet
level
mutant
murin
cell
line
ltkaprt
unabl
mount
antivir
respons
ifnp
treatment
remain
growthinhibit
ifnp
lewi
human
cell
type
describ
express
ifnabr
receptor
subunit
jak
tyk
adequ
level
stat
stat
stat
could
mount
antivir
respons
remain
insensit
growthinhibitori
effect
ifn
basi
human
chromosom
compon
may
confer
ifninduc
growth
inhibit
cell
context
highaffin
interact
ifnabrap
postul
ghislain
et
al
suppress
cmyc
may
play
role
ifn
growth
inhibitori
properti
autocrin
product
ifn
result
cmyc
suppress
arrest
occur
termin
differenti
hematopoiet
cell
resnitzki
et
al
growth
arrest
differenti
downregul
cmyc
synthetas
induct
occur
ml
cell
murin
radiationinduc
acut
myelogen
leukemia
cell
resnitzki
et
al
human
ifnp
inhibit
growth
human
coloncarcinoma
clone
cell
vitro
express
cmyc
protooncogen
posttranscript
destabil
cmyc
mrna
chatterje
savares
investig
found
correl
growth
inhibit
system
activ
induct
synthetas
human
immunodefici
viru
hiv
infect
tcell
correl
growth
inhibit
correl
antivir
state
fujii
et
al
although
ifnp
result
larg
increas
human
prostat
cell
synthetas
activ
neither
increas
dsrnadepend
protein
kinas
pkr
level
rnase
l
activ
could
demonstr
nakajima
et
al
mitogenstimul
smooth
muscl
cell
cultur
ifni
reduc
rate
jh
thymidin
incorpor
delay
time
peak
level
cfo
rna
howev
kinet
characterist
synthetas
induct
cultur
made
unlik
synthetas
account
cytostat
effect
ifni
warner
et
al
alveolar
pulmonari
tumor
cell
maintain
organotyp
cultur
ifni
result
antiprolif
effect
ifna
ifnp
ifni
caus
increas
synthetas
activ
martyr
et
al
synthetas
found
posit
correl
differenti
matur
process
induct
differenti
chemic
cytokin
frequent
associ
synthetas
induct
instanc
synthetas
activ
found
reach
peak
hr
hexamethylen
hisacetamid
induct
termin
differenti
friend
erythroleukemia
cell
even
presenc
antiifncwp
salzberg
et
al
increas
synthetas
observ
human
cell
induc
differenti
dimethyl
sulfoxid
increas
ablat
antiifn
w
schwartz
nilson
induct
differenti
cell
hydroxyvitamin
associ
autocrin
ifn
product
increas
synthetas
testa
et
al
induc
differenti
murin
ml
cell
matur
macrophag
coincid
induct
ifnp
bickel
et
al
howev
observ
induct
synthetas
occur
presenc
antiifnp
antibodi
cycloheximid
character
presenc
two
mrna
speci
kb
wherea
ifnp
induc
kb
mrna
speci
may
result
direct
induct
bind
factor
act
ifnstimulat
respons
element
isr
cohen
et
al
synthetas
activ
increas
found
wide
varieti
cell
type
differenti
differenti
skelet
muscl
cell
sever
speci
found
associ
synthetas
induct
format
decreas
cmyc
express
birnbaum
et
al
induc
growth
arrest
differenti
ml
cell
well
synthetas
induct
synerg
ifni
chen
et
al
ml
variant
resist
differenti
could
activ
synthetas
gene
mous
condylar
cartilag
synthetas
level
found
greatest
prolifer
undifferenti
chondrocyt
wherea
fulli
differenti
chondrocyt
show
lower
level
maor
et
al
primari
chronic
lymphocyt
leukemia
cell
close
correl
synthetas
induct
induct
blast
transform
ostlund
et
al
clone
exhibit
ifninduc
synthetas
increas
blast
transform
occur
synthetas
level
differenti
marker
monitor
human
monocyt
cell
line
promyelocyt
cell
line
cellular
matur
ferbu
et
al
synthetas
level
increas
prior
mani
differenti
marker
rose
matur
process
cell
line
investig
found
causal
connect
synthetas
induct
differenti
human
neuroblastoma
cell
line
sensit
differentiationpromot
effect
ien
corria
et
al
isoform
synthetas
induc
cell
line
ifni
includ
clone
resist
neuron
matur
effect
sodium
butyr
induc
differenti
burkitt
lymphoma
cell
found
caus
rapid
decreas
cmyc
mrna
well
increas
synthetas
mrna
howev
time
cours
synthetas
induct
preclud
direct
effect
polack
et
al
varieti
method
advanc
toward
assay
synthetas
assay
involv
three
separ
stage
isol
synthetas
cell
synthesi
oligonucleotid
measur
oligonucleotid
concentr
tabl
enzymat
synthesi
may
perform
solut
phase
howev
high
degrad
activ
certain
cell
extract
eg
hela
make
problemat
adsorpt
lysatederiv
synthetas
affin
support
follow
atp
mg
k
sometim
dsrna
supplement
subsequ
synthesi
common
hovanessian
et
al
poli
poli
c
link
agaros
sepharos
cellulos
paper
commonli
use
affin
matrix
inhibit
protein
synthesi
evalu
cohcentr
requir
effect
reduct
mrnaprogram
cellfre
system
johnston
et
al
william
et
al
b
nucleas
activ
assay
detect
achiev
rnase
l
activ
rna
cleavag
observ
gel
electrophoresi
specif
wreschner
et
al
gener
william
et
al
rna
cleavag
may
observ
ii
acid
precipit
count
baglioni
et
al
iii
degrad
radiolabel
poli
u
rnase
l
core
ce
u
ose
presenc
silverman
produc
use
radiolabel
atp
separ
excess
atp
use
one
follow
techniqu
hplc
brown
et
al
knight
et
al
util
reversephas
c
column
phosphat
buffer
ph
examin
enzymat
synthes
mixtur
b
column
chromatographi
ion
exchang
media
deaesephadex
cellulos
enabl
atp
separ
highli
charg
core
mink
et
al
hovanessian
et
al
well
et
al
miller
bell
ii
alumina
column
bind
strongli
dimer
tetram
recov
almost
quantit
enabl
detect
small
quantiti
oc
synthetas
revel
et
al
schattner
et
nl
iii
seppak
cartridg
may
use
purifi
oligo
excess
atp
hassel
ts
c
tlc
untreat
separ
use
peicellulos
justesen
er
al
ii
bacteri
alkalin
phosphatas
digest
heterogen
mono
di
triphosph
form
correspond
core
separ
peicellulos
verhaegen
et
al
mink
et
al
iii
hexokinaseglucos
treatment
form
diphosph
deaepap
bind
ball
white
e
electrophoresi
highvoltag
paper
electrophoresi
ii
denatur
polyacrylamid
gel
electrophoresi
separ
enabl
larg
number
sampl
rapidli
process
parallel
miel
er
al
iii
capillari
isotachclphoresi
util
measur
atp
begin
end
reaction
poli
poli
c
agaros
convers
atp
adp
use
hexokinaseglucos
bruchelt
et
al
rnase
l
radiobind
assay
knight
et
al
u
k
n
nown
solut
crude
reaction
mixtur
knight
et
al
hplc
purif
brown
et
al
compet
radiolabel
rnase
l
bind
radioimmunoassay
minim
structur
recogn
knight
et
al
azpa
cailla
et
al
pp
pazpa
sawai
et
al
b
enzym
immunoassay
minim
structur
recogn
azpa
nicola
et
al
c
elisa
minim
structur
recogn
pazpa
pyrophosph
assay
measur
nadph
use
udpglc
pyrophosphorylas
phosphoglucomutas
justesen
kjeldegaard
synthetas
adsorb
poli
poli
c
shown
stabl
demonstr
linear
synthesi
longer
time
hovanessian
et
al
enzym
solut
synthesi
commonli
termin
remcval
reaction
mixtur
support
reaction
done
solut
denatur
enzym
beat
follow
centrifug
initi
effort
determin
concentr
util
known
biolog
activ
tabl
assay
took
advantag
abil
inhibit
protein
synthesi
cellfre
system
examin
rna
cleavag
rnase
l
howev
rel
insensit
inher
variabl
involv
use
complex
biolog
system
assay
method
unsuit
techniqu
routin
analysi
render
limit
interest
number
use
assay
exist
util
incorpor
radiolabel
atp
synthetas
reaction
mixtur
mixtur
radiolabel
core
unphosphoryl
deriv
latter
obtain
treatment
alkalin
phosphatas
separ
sever
method
ionexchang
method
util
alumina
column
deae
sephadex
paper
commonli
use
reversephas
thinlay
chromatographi
tlc
techniqu
also
use
visual
molecul
gener
addit
gel
paper
electrophoresi
well
capillari
isotachophoret
method
adapt
quantit
reaction
product
high
perform
liquid
chromatog
raphi
hplc
remain
power
techniqu
may
use
prepar
well
analyt
separ
radiolabel
oligonucleotid
assay
reli
highaffin
bind
rnase
l
knight
et
al
monoclon
antibodi
advantag
high
specif
sensit
knight
et
al
wlsuccinyl
cailla
et
al
bind
antibodi
compet
nanomolar
concentr
unlabel
howev
antibodi
assay
crossreact
may
present
millimolar
rang
problemat
latter
may
remov
assay
perform
final
enzym
immunoassay
elisa
coupl
spectrophotometr
assay
advantag
radiolabel
mixtur
radiolabel
probe
need
gener
tabl
enpolog
synthetas
catalyz
follow
reaction
natp
n
ppi
n
addit
catalyz
polymer
atp
enzym
may
also
function
ball
white
johnston
et
al
ferbu
et
al
singl
addit
differ
riboand
deoxyribonucleotid
triphosph
onto
occur
hugh
et
al
although
phosphorothio
atp
analogu
kariko
et
al
seem
act
chain
termin
synthetas
also
elong
variou
oligonucleotid
primer
termin
adenosin
free
exist
ball
white
mink
et
al
ferbu
et
al
sinc
synthetas
nad
ap
therebi
inactiv
initi
specul
synthetas
play
role
cellular
metabol
rout
howev
date
intermedi
identifi
cell
use
radiobind
assay
discuss
synthetas
purifi
homogen
human
hela
namalva
cell
mous
l
eat
cell
line
well
rabbit
reticulocyt
tabl
common
purif
step
includ
ammonium
sulfat
methanol
precipit
deaecellulos
chromatographi
well
et
al
dougherti
et
al
ball
conveni
overal
scheme
requir
ultracentrifug
yang
et
al
use
immunoaffin
column
mari
et
al
purifi
two
isoform
homogen
necessari
purif
step
chromatographi
poli
ri
poli
rc
cellulos
poli
ri
poli
rc
agaros
enzym
unstabl
absenc
dsrna
rovnak
ranu
yang
et
al
found
atp
dsrna
bsa
nonion
deter
yang
et
al
well
et
al
revel
et
al
ilson
et
al
raher
et
al
revel
et
al
merlin
et
al
benech
et
al
benech
et
al
chebath
et
al
saunder
et
al
shiojiri
et
al
revel
et
al
dougherti
et
al
st
laurent
et
al
raber
et
al
well
et
al
rovnak
ranu
shimizu
sokawa
shimizu
et
al
ball
white
ball
gf
gel
filtrat
cc
glycerol
gradient
densiti
centrifug
gent
triton
nonidet
stabil
enzym
k
synthetas
mm
atp
ad
util
optim
mg
concentr
mm
consensu
mode
chain
elong
nonprocess
johnston
et
al
justesen
et
al
imai
et
al
see
mink
et
al
intermedi
dissoci
enzym
addit
anoth
nucleotid
unit
experi
confirm
purifi
synthetas
isoform
perform
human
synthetas
access
number
synthetas
access
number
clone
wathelet
et
al
mari
hovanessian
howev
human
report
yet
clone
synthetas
code
kb
mrna
deriv
gene
cell
typespecif
differenti
splice
addit
exon
gene
benech
et
al
local
chromosom
kb
rna
code
amino
acid
ctermin
hydrophob
protein
kb
rna
code
amino
acid
ctermin
acid
protein
benech
et
al
saunder
et
al
hovanessian
et
al
synthetas
contain
two
homolog
subdomain
contain
atp
bind
motif
glyglyserxglyalalysarg
well
dsrnabind
domain
addit
contain
one
domain
tlasi
gelfiltr
experi
mari
et
al
b
former
evid
like
well
probabl
exist
tetram
dimer
respect
possess
two
catalyt
domain
hand
synthetas
probabl
exist
monom
mari
et
al
consist
observ
role
product
dimer
also
tempt
specul
gene
may
evolv
ancestr
fusion
two
gene
four
form
synthetas
isol
varieti
human
cell
line
pbmc
howev
number
biochem
function
differ
although
isoform
nduce
ifnol
p
provid
cell
type
respons
type
ifn
celltyp
mari
et
al
patientspecif
witt
et
al
differ
doserespons
kinet
synthetas
isoform
synthesi
differ
subcellular
local
also
occur
local
cytoplasm
myristoyl
found
closer
associ
nuclear
membran
mari
et
al
present
cell
membran
well
microsom
pellet
found
microsom
hovanessian
et
al
synthetas
local
primarili
nuclei
chebath
et
al
synthetas
higher
k
atp
requir
less
dsrna
manufactur
requir
acid
ph
produc
longer
oligom
addit
maxim
synthesi
occur
earlier
respons
ifn
although
four
isoform
antigen
dissimilar
share
common
epitop
chebath
et
al
bind
type
ifn
led
tyrosin
phosphoryl
human
ifncl
receptor
peptid
ifnabra
activ
phosphoryl
latent
transcript
factor
bind
isr
see
pellegrini
schindler
kda
isoform
synthetas
express
glutathion
stransferas
fusion
protein
e
coli
kon
suhadolnik
coval
linkag
sazido
zp
atp
photoprob
synthetas
tryptic
digest
bioconjug
isol
label
peptid
metal
chelat
chromatographi
reveal
pentapeptid
put
atp
bind
site
sequenc
photoprob
modifi
lysin
sitedirect
mutagenesi
lysin
confirm
result
bind
site
dsrna
synthetas
isoform
well
defin
ghosh
et
al
investig
small
mous
synthetas
found
linear
region
residu
amino
termin
domain
necessari
dsrna
bind
sequenc
show
homolog
mous
rat
synthetas
truve
et
al
postul
dsrna
bind
site
though
human
wathelet
et
al
show
homolog
region
littl
homolog
human
mari
hovanessian
sequenc
begin
residu
residu
contain
lysin
arginin
residu
strictli
conserv
moreov
dsrnabind
domain
dsrnaactiv
protein
kinas
pkr
share
dsrna
bind
protein
number
organ
st
johnston
et
al
synthetas
appear
belong
complet
differ
famili
dsrna
bind
protein
maxim
synthetas
activ
requir
presenc
bp
long
dsrna
mink
et
al
b
c
samanta
et
al
dsrna
remov
synthetas
reaction
rnase
iii
treatment
reaction
stop
mink
et
al
influenc
dsrna
structur
activ
extens
explor
protein
purifi
immunoaffin
chromatographi
activ
poli
poli
c
well
poli
poli
u
though
latter
homopolymeractiv
somewhat
less
well
former
mari
et
al
singlestrand
rna
ssrna
could
activ
synthetas
studi
although
isoform
could
bind
ssrnasepharos
bound
enzym
could
becom
activ
poli
poli
c
basi
presenc
multipl
polynucleotid
bind
site
postul
mari
et
al
partli
dsrna
adenovir
rna
bind
pkr
protein
synthetas
synthetas
activ
rna
desai
et
al
misalign
dsrna
poli
poli
clzu
also
shown
potent
activ
synthetas
vitro
viva
carter
et
al
li
et
al
ushijima
et
al
poli
pli
cu
also
less
toxic
less
pyrogeni
less
antigen
poli
poli
c
johnston
synthet
heteropolymer
dsrna
also
prepar
found
activ
synthetas
hain
et
al
possess
restrict
biolog
activ
howev
unabl
inhibit
growth
cell
vitro
induc
ifnp
illa
gene
express
structureact
studi
demonstr
neither
ssrna
triplestrand
rna
complet
substitut
poli
poli
c
h
och
n
f
cl
result
activ
johnston
et
al
baglioni
et
al
torrenc
et
al
torrenc
friedman
synthetas
howev
toler
methyl
substitut
pkr
mink
et
al
natur
dsrna
phage
fi
killer
yeast
pen
urn
chrysogenum
found
good
synthetas
activ
adenovir
rna
highli
structur
solut
bind
activ
synthetas
consequ
two
long
imperfectli
pair
stem
structur
desai
et
al
matthew
shenk
imperfect
pair
repair
synthetas
activ
even
greater
degre
emcv
rna
also
found
bound
synthetas
immunoprecipit
partial
activ
even
without
addit
dsrna
precipit
uninfect
cell
gribaudo
et
al
hiv
trunsactiv
region
tar
abl
bind
activ
synthetas
vitro
sengupta
silverman
maitra
et
al
effect
tar
synthetas
activ
abolish
tat
protein
schroder
et
al
silverman
sengupta
heterogen
nuclear
rna
hnrna
pbmc
patient
hairi
cell
leukemia
hela
cell
activ
synthetas
suggest
possibl
role
hnrna
process
nilsen
et
al
hubbel
et
al
synthetas
also
found
associ
spliceosom
could
immunoprecipit
antism
antibodi
synthetas
antibodi
also
found
inhibit
splice
reaction
vitro
result
defici
splice
activ
ad
hela
cell
nuclear
extract
sperl
et
al
remark
synthetas
lymphocyt
autoimmun
bb
rat
sensit
stimul
dsrna
bonnevienielsen
et
al
overwhelm
major
data
consist
view
rnase
l
present
avian
reptilian
mammalian
speci
insect
fish
plant
bacteria
reptil
avian
speci
shown
possess
bind
activ
presum
rnase
l
number
studi
ball
white
b
cayley
et
al
fact
liver
kidney
cardiac
tissu
number
reptilian
speci
shown
high
bind
activ
cayley
et
al
murin
rabbit
tissu
rnase
l
found
list
tabl
enzym
also
found
larg
number
human
cell
type
absenc
ifn
treatment
one
studi
murin
spleen
tissu
extract
highest
level
rnase
l
liver
extract
lowest
level
measur
radiobind
assay
floydsmith
denton
lung
kidney
extract
moder
level
ifnp
affect
observ
basal
level
rnase
l
present
tissu
rabbit
antimous
ifnci
decreas
level
rnase
l
spleen
suggest
endogen
ifnap
respons
mainten
rnase
l
level
organ
uivo
mice
rnase
l
level
highest
spleen
lung
liver
kidney
day
age
decreas
age
except
spleen
remain
high
adulthood
floydsmith
denton
may
relev
particip
rnase
l
system
certain
agespecif
viral
diseas
major
studi
identifi
nuclear
cytoplasm
local
rnase
l
nilsen
et
al
ba
bayard
gabrion
yard
gabrion
schroder
et
al
enzym
associ
polysom
cytoplasm
salehzada
et
al
nuclear
matric
nucleu
basal
level
rnase
l
exist
wide
varieti
differenti
cell
type
low
constant
level
howev
cell
type
rnase
l
may
highli
regul
murin
cell
rnase
l
level
cncreas
ifn
treatment
respons
block
treatment
actinomycin
suggest
transcript
involv
jacobsen
et
al
b
furthermor
lofold
increas
rnase
l
level
could
observ
cell
type
growth
arrest
confluenc
nih
cell
growth
arrest
confluenc
caus
induct
rnase
l
level
could
increas
still
ifn
treatment
kraus
et
al
b
rnase
l
mrna
level
increas
murin
cell
respons
ifn
treatment
unaffect
cycloheximid
number
indic
rnase
l
function
control
cell
growth
differenti
document
rnase
l
synthetas
level
often
found
elev
cell
differenti
well
growtharrest
cell
addit
introduct
cell
effect
impair
cell
growth
sen
lengyel
zhou
et
al
kraus
et
al
b
demonstr
differenti
regul
rnase
l
variou
cell
line
respons
induc
differenti
ifn
treatment
measur
breakdown
rrna
caus
introduct
za
cell
rnase
l
induct
ifn
demonstr
three
differenti
cell
type
clone
py
psa
howev
three
undifferenti
cell
line
clone
nulli
littl
rnase
l
without
ifn
treatment
addit
induc
differenti
clone
cell
concomit
induct
rnase
l
paradox
recent
studi
suggest
rnase
l
level
may
increas
lofold
rapidli
divid
tissu
obtain
colorect
tumor
respect
normal
colon
mucosa
increas
rnase
l
level
also
found
occur
earli
colorect
tumorigenesi
effect
microwav
radiat
synthetas
rnase
l
level
investig
kraus
et
al
although
dierenc
synthetas
level
found
rnase
l
induc
measur
bind
gene
rnase
l
known
fourth
rnase
map
human
genom
squir
et
al
region
assign
made
use
fluoresc
situ
hybrid
use
rnase
l
genom
clone
isol
human
placenta
cosmid
librari
posit
hybrid
signal
found
metaphas
spread
sinc
gene
synthetas
map
chromosom
gene
system
form
gene
cluster
human
genom
evid
defect
directli
link
human
diseas
howev
number
abnorm
coloc
lq
defect
charcotmarietooth
diseas
cmtlb
locu
local
lebo
et
al
multipl
congenit
anomali
development
delay
found
one
patient
interstiti
delet
et
al
significantli
number
human
cancer
found
associ
lq
abnorm
includ
gastric
adenocarcinoma
et
al
oral
squamou
cell
carcinoma
kerr
brown
breast
cancer
chen
et
al
pathak
et
al
neg
growth
regulatori
function
rnase
l
may
consid
candid
tumorsuppressor
gene
bork
sander
found
ntermin
residu
contain
ankyrin
ank
repeat
averag
length
residu
sequenc
homolog
human
erythrocyt
ank
ank
repeat
occur
consecut
copi
larg
number
function
variabl
protein
shown
mediat
proteinprotein
proteindna
interact
protein
kinas
domain
identifi
follow
ank
repeat
previou
identif
ploop
motif
challeng
group
bork
sander
nevertheless
ank
repeat
contain
like
bind
site
whether
associ
two
ploop
protein
kinas
homolog
domain
probabl
contain
atp
bind
site
domain
necessari
catalyt
activ
resid
ctermin
portion
enzym
dong
silverman
perform
progress
truncat
studi
either
terminu
rnase
l
develop
bipartit
model
structur
rnase
l
regulatori
function
assign
ntermin
half
enzym
catalyt
function
assign
ctermin
half
process
studi
dong
silverman
abl
produc
delet
amino
acid
nterminu
constitut
activ
ribonucleas
reduc
activ
compar
wildtyp
enzym
recombin
rnase
l
recent
express
baculoviru
system
purifi
report
homogen
human
rnase
l
cdna
sub
recombin
enzym
evalu
activ
requir
dimer
oligoadenyl
ppp
complet
fail
activ
rnase
l
link
core
oligoadenyl
greatli
reduc
abil
activ
enzym
longer
oligom
well
monophosph
maxim
activ
nm
extens
dialysi
remov
dival
cation
effect
enzym
activ
measur
poli
u
degrad
assay
also
determin
although
recombin
rnase
l
residu
abil
cleav
poli
u
even
complet
absenc
metal
ion
addit
atp
plu
mg
cation
slightli
lesser
extent
atp
plu
mn
cation
significantli
stimul
rnase
l
activ
addit
ca
ion
alon
inhibitori
addit
zn
ion
even
presenc
atp
l
molar
ratio
rnase
l
determin
glycerol
gradient
centrifug
chemic
crosslink
gel
filtrat
complet
convers
homodimer
form
monom
observ
addit
core
oligoadenyl
ineffect
promot
dimer
may
indic
presenc
share
catalyt
site
rna
degrad
rnase
l
poli
rg
poli
rc
poli
da
poli
dt
cleav
recombin
enzym
poli
ra
degrad
somewhat
poli
ru
degrad
effici
fragment
rang
size
nucleotid
length
first
observ
irrevers
loss
rnase
l
activ
caus
gel
filtrat
sephadex
column
could
prevent
addit
atp
adp
buffer
wreschner
et
al
recent
work
purifi
mous
human
rnase
l
show
stimulatori
effect
atp
rnase
l
activ
presenc
silverman
et
al
dong
et
al
earlier
result
notwithstand
atp
omit
purif
step
rnase
l
activ
fulli
recov
observ
repeat
author
laboratori
player
e
wondrak
p
f
torrenc
unpublish
observ
rnase
l
activ
also
requir
presenc
mg
although
mn
also
function
support
catalyt
activ
minim
level
activ
remain
absenc
dival
cation
reduc
agent
dithiothreitol
also
necessari
maintain
bind
activ
ribonucleas
bayard
et
al
although
detail
studi
avail
rnase
l
found
exist
monomer
state
hela
cell
mous
thymoma
cell
nilsen
et
al
howev
murin
eat
cell
mous
splenocyt
also
found
contain
dimer
approxim
twice
weight
slatteri
et
al
bayard
et
al
addit
studi
murin
ehrlich
ascit
tumor
cellderiv
rnase
l
report
behav
kda
speci
gel
filtrat
sdspage
analysi
affinitylabel
rnase
l
gave
result
kda
bisbal
et
al
howev
latter
author
found
anoth
kda
speci
bore
similar
rnase
l
partial
proteolysi
proteas
inhibitor
report
alter
level
kda
protein
signific
remain
unknown
also
propos
rnase
l
consist
heterodim
regulatori
subunit
bind
catalyt
subunit
rna
bind
salehzada
et
al
recent
work
base
chemic
crosslink
gel
filtrat
glycerol
gradient
sediment
demonstr
enzym
homodim
presenc
molar
equival
monom
absenc
cole
et
al
oligoadenyl
caus
dimer
rnase
l
usual
activ
well
core
oligoadenyl
capabl
activ
rnase
l
similarli
ineffici
dimer
dimer
rnase
l
studi
equilibrium
sediment
techniqu
enzym
found
dimer
presenc
synthet
oligoribonucleotid
substrat
presenc
atp
alon
cole
et
al
howev
presenc
satur
pa
enzym
fulli
dimer
protein
concentr
low
nm
absenc
activ
dimer
observ
protein
concentr
high
mm
evalu
kinet
cleavag
pkr
mrna
context
antisens
chimera
perform
maitra
et
al
antisens
chimera
pkr
mrna
well
tetram
found
activ
respect
antisens
chimera
tae
antisens
sequenc
complementari
pkr
mrna
target
addit
k
found
secci
impli
molecul
rnase
l
abl
catalyz
cleavag
multipl
mrna
strand
site
cleavag
also
map
discret
site
along
pkf
mrna
use
primer
extens
analysi
recogn
prefer
cleavag
upnp
alter
approach
clear
prefer
specif
base
observ
although
classic
method
assay
reli
cleavag
radiolabel
poli
u
silverman
cleavag
ribosom
rna
rrna
kariko
et
al
b
recent
method
util
cleavag
radiolabel
oligoribonucleotid
sinc
rnase
l
cleav
preferenti
uu
ua
sequenc
wreschner
et
al
sequenc
chosen
kinet
analysi
rnase
l
comparison
primari
cleavag
product
cleavag
product
result
rnase
phym
basecatalyz
hydrolysi
confirm
p
uup
primari
cleavag
product
rnase
l
ad
reaction
mixtur
contain
substrat
pa
initi
lag
product
format
occur
could
allevi
incub
rnase
l
pa
rate
cleavag
linear
pm
use
rnase
l
preactiv
nm
pa
rate
cleavag
halfmaxim
nm
pa
attain
maxim
veloc
nm
pa
abcv
longer
oligoribonucleotid
cleav
efficienrli
instanc
cleav
less
effici
k
k
primarili
due
increas
k
addit
rnase
l
catalyz
cleavag
substrat
contain
sequenti
u
faster
rate
catalyz
cleavag
substrat
contain
singl
u
system
rnase
l
rapidli
evolv
complex
salehzada
et
al
separ
studi
bayard
et
al
employ
tetramer
ppp
periodateoxid
coval
bound
hexanolc
hydrazid
agaros
affin
purifi
rnase
l
g
supernat
mous
spleen
highli
purifi
enzym
homogen
could
elut
affin
column
ph
glycin
buffer
presenc
tritonx
purifi
nucleas
stabil
affin
label
migrat
kda
protein
kda
protein
denatur
sdspage
condit
similar
studi
cellular
extract
impli
enzym
compris
kda
kda
speci
absenc
appar
dimer
kda
speci
bound
minim
addit
surprisingli
poli
u
could
maxim
bind
elut
kda
nucleas
show
residu
activ
even
absenc
find
led
bayard
et
al
suggest
poli
u
substrat
induc
conform
chang
rnase
l
chang
facilit
bind
bayard
et
al
also
postul
loss
regulatori
protein
purif
order
account
low
level
nucleas
activ
yet
anoth
chapter
complex
system
ad
find
bisbal
et
al
isol
polypeptid
inhibitor
term
rli
system
base
screen
express
librari
assay
bind
radioact
protein
propos
regul
would
inhibit
bind
rnase
l
therebi
block
activ
rnase
l
nucleas
activ
although
rli
poor
affin
rnase
l
may
associ
directli
noncoval
enzym
alter
activ
potenti
overexpress
rli
hela
cell
partli
antagon
antipicornavir
effect
ifn
essenc
present
state
affair
regard
rnase
l
function
catalyt
structur
may
express
two
differ
scenario
one
hand
suggest
work
dong
et
al
cole
et
al
rnase
l
appear
kda
protein
dimer
presenc
activ
perhap
give
actual
catalyt
conform
hand
repres
data
bayard
et
al
salehzada
et
al
rnase
l
may
consist
two
differ
kda
protein
one
bind
anoth
bind
rna
substrat
activ
enzym
could
inhibit
yet
anoth
protein
bind
rnase
l
critic
question
whether
system
might
differenti
rna
substrat
ie
viral
vs
cellular
intact
host
cell
partial
purifi
rnase
l
murin
eat
cell
found
degrad
poli
u
four
homopolym
poli
u
poli
c
poli
g
poli
floydsmith
et
al
phage
rna
segment
frequent
cut
found
ua
ug
uu
minor
cleavag
ca
rare
cleavag
ac
cg
floydsmith
et
al
rnase
l
isol
rabbit
reticulocyt
human
lymphoblastoid
cell
murin
eat
cell
cleav
viral
rrna
substrat
uu
ua
sequenc
possibl
result
secondari
structur
wreschner
et
al
b
gener
rnase
l
cleavag
occur
p
termin
product
wreschner
et
al
b
cleavag
experi
purifi
recombin
human
rnase
l
yield
similar
result
except
ineffici
cleavag
poli
observ
exist
cut
predominantli
singlestrand
region
phage
rna
floydsmith
et
al
report
absenc
cleavag
poli
poli
u
nilsen
et
al
establish
depend
site
extent
cleavag
rna
secondari
structur
poorli
understood
addit
degrad
poli
u
observ
gener
discret
fragment
nucleotid
length
end
product
unknown
reason
nilsen
baglioni
nuclear
extract
hela
cell
found
contain
nanomolar
quantiti
activ
bound
affin
similar
rnase
l
nucleic
acid
hnrna
contain
duplex
structur
found
promot
synthesi
preferenti
cleav
ifntreat
cell
extract
nilsen
et
al
nascent
reoviru
rna
prepar
transcript
simpl
uv
irradi
use
crosslink
rnase
l
studi
floydsmith
et
al
photoactivat
azido
deriv
also
report
suhadolnik
et
al
use
greatli
examin
bind
analogu
rnase
l
tetram
eg
ppp
link
pcp
use
rna
ligas
knight
et
al
result
radioact
probe
may
compet
number
analogu
bind
measur
compar
sever
techniqu
use
evalu
activ
rnase
l
rel
contribut
bind
versu
activ
variou
structur
domain
may
compar
lewi
falcoff
earli
method
involv
abil
analogu
inhibit
cellfre
protein
synthesi
specif
mrna
torrenc
friedman
anoth
method
use
properti
caus
specif
cleavag
rrna
evalu
cellfre
system
examin
agaros
gel
electrophoresi
wreschner
et
al
perhap
frequent
employ
assay
use
poli
ru
pcp
result
poli
ru
pcp
product
evalu
substrat
rnase
l
measur
trichloroacet
acidprecipit
radioact
respons
activ
enzym
analogu
order
distinguish
cleavag
caus
rnase
l
oppos
cellular
nucleas
rnase
l
first
must
immobil
core
cellulos
wash
free
contamin
nucleas
contrast
purifi
human
recombin
enzym
carrol
et
al
abl
employ
uupc
synthet
substrat
although
synthetas
gener
oligom
dimer
product
longer
decam
oligoadenyl
must
trimer
longer
order
effect
bind
activ
rnase
l
eg
torrenc
et
al
johnston
torrenc
oligom
greater
length
trimer
bind
activ
enzym
approxim
equal
well
limit
evid
tissuespecif
differ
oligom
size
activ
requir
rnase
l
kraus
silverman
wu
et
al
rnase
l
rabbit
reticulocyt
lysat
thu
far
uniqu
requir
tetram
instead
trimer
activ
measur
corecellulos
assay
respect
abil
caus
inhibit
translat
reticulocyt
cellfre
system
rabbit
kidney
cell
rnase
l
howev
well
murin
reticulocyt
rnase
l
activ
trimer
tetram
zolat
tri
nbutylammonium
pyrophosph
evalu
translat
inhibitor
use
emcv
rnaprogram
lcell
extract
found
approxim
time
less
efficaci
phosphodiest
linkag
analogu
time
less
effect
translat
inhibitor
addit
time
less
effect
displac
p
p
radiobind
assay
monophosph
linkag
isom
show
similar
pattern
activ
doetsch
et
al
structur
proof
consist
sole
r
comparison
radiolabel
alkalin
phosphatasedigest
product
wellcharacter
chemic
synthes
core
charubala
pfleider
b
singl
tlc
system
although
found
potent
translat
inhibitor
trimer
tetram
rabbit
reticulocyt
cellfre
system
doetsch
et
al
group
william
et
al
found
trimer
subnanomolar
activ
nucleas
contrast
rabbit
cell
type
murin
human
line
examin
thu
far
triphosph
core
cordycepin
analogu
trimer
tetram
prepar
character
four
group
sawai
et
al
haugh
et
al
nyila
et
al
charubala
pfleider
b
product
character
enzymatit
physic
core
oligonucleotid
produc
charubala
pfleider
ident
phosphoryl
produc
sawai
et
al
alkalin
phosphatas
digest
product
latter
also
found
ident
charubala
pfleider
core
trimer
product
cordycepin
analogu
examin
number
differ
assay
system
lysat
pp
found
bind
rnase
l
time
less
well
activ
nucleas
x
less
potent
judg
inhibit
emcv
rna
translat
sawai
et
al
globin
mrnaprogram
rabbit
reticulocyt
cell
lysat
cordycepin
trimer
analogu
activ
micromolar
concentr
howev
tetram
evalu
condit
cordycepin
analogu
less
potent
sawai
et
al
haugh
et
al
find
activ
rnase
l
lcell
daudi
cell
extract
kraus
et
al
found
activ
corecellulosepoli
u
pcp
degrad
assay
calcium
coprecipit
use
introduc
intact
lcell
found
time
less
potent
measur
inhibit
protein
synthesi
eppstein
et
al
examin
activ
mous
eat
cell
none
found
activ
lcell
extract
minim
nyila
et
al
sinc
replac
ribos
moieti
cordycepin
posit
result
virtual
complet
loss
activ
effect
introduct
one
posit
trimer
examin
torrenc
et
al
evalu
bind
equival
activ
approxim
time
less
potent
measur
translat
inhibit
poli
u
degrad
assay
increas
bind
activ
observ
howev
display
decreas
bind
activ
rnase
l
decreas
looofold
therefor
second
nucleotid
residu
critic
bind
rnase
l
baglioni
et
al
lofold
less
effect
activ
rnase
l
reduct
activ
relat
correspond
decreas
bind
rnase
l
individu
diastereomer
core
p
prepar
modifi
hydroxybenzotriazol
phosphotriest
approach
de
vroom
et
al
deriv
phosphoryl
phosphomorpholid
synthesi
resolut
pthioadenylyl
pthioadenylyl
pthioadenylyl
adenosin
core
first
perform
charubala
et
al
diasterom
bound
equal
well
cell
lysatederiv
rnase
l
core
cellulos
assay
activ
enzym
except
spspsp
isom
antagonist
four
diastereom
pthioadenylyl
pthioadenylyl
adenosin
synthes
none
compound
bind
activ
rnase
l
phosphorothio
analogu
dimer
trimer
core
well
prepar
phosphoramidit
method
diasterom
separ
chromatograph
mean
fulli
character
physic
mean
charubala
pfleider
trimer
core
also
prepar
via
ioncatalyz
polymer
shimazu
et
al
oligom
contain
preponder
linkag
rp
configur
dimer
core
sp
stereoselect
attain
use
hydrogen
phosphon
methodolog
follow
oxid
phosphoryl
battistini
et
al
base
replac
common
nucleotid
form
n
loss
rnase
l
activ
abil
result
although
antagon
action
still
possibl
drocourt
et
al
replac
first
base
hypoxanthin
give
result
loss
activ
abil
well
bind
affin
replac
second
base
yield
yield
decreas
activ
abil
decreas
bind
affin
replac
hypoxanthin
give
result
looofold
loss
activ
abil
measur
inhibit
translat
decreas
bind
affin
therefor
ntne
adenosin
requir
bind
rnase
l
adenosin
requir
effect
activ
rnase
l
bind
evid
import
moieti
adenosin
shown
synthesi
time
less
effect
bind
murin
rnase
l
jamoul
torrenc
undin
substitut
variou
posit
trimer
substanti
result
obtain
inosinemodifi
analogu
kitad
et
al
thu
substitut
form
caus
loofold
decreas
bind
activ
replac
termin
caus
decreas
activ
replac
middl
adenosin
form
show
correspondingli
larger
decreas
activ
abil
inosin
analogu
expect
inosin
analogu
studi
format
sequencespecif
analogu
tubercidin
corrobor
result
mention
abop
jamoul
et
al
tubercidin
analogu
bound
almost
well
trimer
incap
activ
nucleas
evalu
larg
decreas
activ
abil
moder
loss
bind
abil
observ
show
neglig
reduct
activ
abil
despit
moder
loss
bind
abil
thu
situat
somewhat
reminisc
inosin
uridin
analogu
base
moieti
second
nucleotid
unit
appear
play
less
import
role
rnase
l
activ
first
third
adenin
trimer
would
also
appear
purin
latter
two
adenin
site
may
import
contributor
bindingactiv
process
jamoul
et
al
substitut
bromin
purin
h
also
moder
bind
actvat
abil
lesiak
torrenc
p
brsa
p
brsa
led
lo
fold
decreas
activ
directli
attribut
decreas
bind
affin
brsa
activ
murin
rnase
l
lofold
effect
measur
inhibit
translat
conform
studi
bromin
analogu
reveal
good
bind
rnase
l
requir
anti
orient
base
glycosid
bond
adenosin
van
den
hoogen
et
al
addit
n
basesugar
orient
stype
sugar
conform
adenosin
may
posit
influenc
bind
rnase
l
studi
analogu
confirm
result
kitad
et
al
introduct
posit
result
decreas
bind
affin
concomit
decreas
activ
abil
introduct
yield
analogu
activ
better
rnase
l
deriv
line
mous
lcell
requir
effect
activ
howev
sever
ration
modif
obviat
necess
polyphosph
present
problem
refer
increas
charg
diminish
cellular
uptak
well
increas
suscept
cellular
phosphatas
phosphodiesteras
tend
decreas
biolog
activ
although
substitut
lcell
line
requir
absolut
kovac
et
al
one
lcell
line
mous
liver
extract
requir
former
case
serv
effect
antagonist
sever
deriv
found
mitig
necess
br
tetram
found
effect
activ
mous
lcell
determin
inhibit
translat
well
stabl
toward
cellular
phosphodiesteras
torrenc
et
al
modif
baglioni
et
al
report
p
ymethylen
phosphon
analogu
trimer
triphosph
could
activ
enzym
judg
protein
synthesi
inhibit
still
could
bind
rnase
l
ascertain
abil
inhibit
action
contrast
p
ydifluoromethylen
analogu
show
signific
activ
possibl
due
closer
correspond
pka
polyphosph
moieti
natur
compar
unsubstitut
methylen
analogu
bisbal
et
al
addit
yphosphorothio
analogu
pthiophosph
analogu
effect
activ
rnase
l
bisbal
et
al
uran
acid
analogu
show
trace
activ
rnase
l
activ
kinjo
et
al
sever
addit
modif
discuss
section
relat
antagon
rnase
l
ifn
action
see
also
meur
et
al
picornavirus
nake
icosahedr
nucleocapsid
nm
diamet
core
ssrna
subdivid
four
genera
enteroviru
cardioviru
rhinovi
anhexylmopholin
anhexylmopholin
ppp
pp
tetramer
congen
p
ch
pycfzaq
oxr
pppsand
torrenc
et
al
unpublish
miyamoto
et
al
haugh
et
al
jamoul
et
al
black
et
al
lesiak
torrenc
imai
et
al
sawai
et
al
torrenc
et
al
haugh
et
al
watl
et
al
bisbal
et
al
ru
aphthoviru
replic
cycl
signific
capac
product
larg
amount
dsrna
instanc
polioviru
wellstudi
member
enteroviru
genera
parent
genom
function
mrna
product
polyprotein
doublestrand
replic
form
transcrib
result
product
progeni
plu
strand
peel
mechan
emcv
cardioviru
caus
mild
febril
ill
number
speci
includ
human
often
evalu
conjunct
system
accumul
measur
rrna
cleavag
observ
emcvtreat
ifntreat
cell
wreschner
et
al
silverman
et
al
silverman
et
al
william
et
al
knight
et
al
well
organ
emcvinfect
mice
observ
induc
rrna
cleavag
product
possibl
short
halflif
replic
intermedi
munoz
et
al
evid
implic
system
antivir
effect
ifn
increas
level
resist
emcv
infect
occur
human
glioblastoma
cell
stabli
transfect
human
synthetas
cdna
result
constitut
synthetas
product
rysiecki
et
al
similar
studi
transfect
murin
cdna
encod
synthetas
nih
cell
result
vari
level
constitut
synthetas
product
well
greatli
increas
resist
emcv
infect
vsv
infect
coccia
et
al
chebath
et
al
transfect
competit
inhibitor
p
rnase
l
calcium
phosphat
coprecipit
greatli
reduc
antiemcv
effect
ifn
measur
absenc
characterist
rrna
cleavag
pattern
watl
et
al
nilsen
et
al
nilsen
et
al
poxvirus
nm
complex
brickshap
particl
contain
complex
dna
genom
vaccinia
viru
member
orthopoxviru
genu
possess
replic
cycl
involv
product
dsrna
number
studi
found
larg
small
increas
level
activ
rnase
l
characterist
rrna
breakdown
vacciniaviru
infect
ifntreat
cell
rice
et
al
goswami
sharma
sever
vaccinia
protein
may
mitig
enhanc
abil
system
particip
antivir
activ
ifn
instanc
mutat
gene
express
product
may
play
role
viral
replic
effect
enhanc
level
synthetas
rnase
l
specif
method
poxvirus
may
escap
system
control
remain
determin
molecul
may
inhibit
antagon
action
tabl
fm
relief
dsrnamedi
inhibit
translat
could
obtain
studi
conduct
cellfre
system
use
phosphodiesterasestabil
antagonist
p
nhexylmopholinetermin
reveal
even
allow
made
substanti
concentr
gener
poli
poli
c
activ
synthetas
signific
translat
inhibitori
compon
prevent
amagonist
remain
thu
primari
mediat
poli
poli
c
induc
translat
repress
particular
cellfre
system
given
condit
anoth
mechan
protein
kinas
appar
oper
also
rel
contribut
ribonucleas
mechan
dsrna
action
lengyel
vari
depend
upon
exact
particular
effect
inhibitor
activ
rnase
l
mous
lcell
extract
line
mous
lcell
miyamoto
et
al
black
et
al
haugh
et
al
gener
applic
cellfre
system
intact
cell
system
cultur
mous
lcell
haugh
et
al
cellfre
extract
daudi
lymphoblastoid
cell
hela
cell
haugh
et
al
lesiak
torrenc
mimic
action
case
could
due
convers
correspond
case
human
cell
howev
establish
pure
human
rnase
l
activ
equal
well
striphosph
thu
use
antagonist
action
humanderiv
system
follow
lead
torrenc
et
al
watl
cowork
employ
analogueinhibitor
antagonist
action
intact
cell
molecul
consist
trimer
termin
modifi
methylthiophosph
phosphatas
protect
protect
group
provid
resist
phosphodiesteras
degrad
enhanc
precipit
calcium
phosphat
use
transfect
procedur
introduc
analogu
cell
upon
calcium
phosphat
transfect
analogu
inhibitor
abbrevi
ch
p
could
block
activ
rnase
l
cellfre
extract
intact
cell
importantli
ifntreat
encephalomyocarditisinfect
cell
analogu
calcium
phosphateaid
uptak
could
inhibit
rrna
cleavag
also
could
restor
partial
synthesi
emcv
rna
synthesi
viru
yield
partial
revers
viru
replic
p
taken
evid
implic
system
inhibit
emcv
growth
ifn
watl
et
al
howev
sinc
revers
best
clear
whether
repres
system
maximum
contribut
antiemcv
effect
ifn
whether
compensatori
action
differ
mechan
eg
pkr
occur
larg
varieti
studi
implic
part
system
fig
variou
biolog
phenomena
regener
rat
liver
bucher
malt
provid
model
system
potenti
role
examin
smekensetienn
et
al
etiennesmeken
et
al
studi
level
anoth
system
provid
evid
biolog
role
system
involv
estrogen
administr
immatur
chick
estrogen
treatment
lead
differenti
growth
tubular
gland
cell
oviduct
egg
white
protein
predominantli
ovalbumin
synthes
tubular
gland
cell
schimk
et
al
omalley
et
al
palmit
et
al
estrogen
treatment
discontinu
result
gradual
week
declin
ovalbumin
synthesi
decreas
oviduct
size
egg
white
protein
oviduct
growth
may
reinduc
varieti
agent
includ
estrogen
progesteron
glucocorticoid
carcinogen
tumor
promot
review
cohr
et
al
initi
primari
stimul
occur
estrogen
rapid
acut
withdraw
estrogen
surgic
remov
diethylstilbestrol
implant
caus
inhibit
transcript
egg
white
protein
mrna
speedi
degrad
exist
hormoneinduc
mrna
review
cohr
et
al
ovalbumin
mrna
halflif
reduc
hr
hormonetr
chick
oviduct
hr
hormonewithdrawn
chick
oviduct
restimul
led
new
ovalbumin
mrna
transcript
stark
et
al
report
synthetas
present
low
undetect
level
restimul
oviduct
estrogen
estrogen
withdraw
activ
synthetas
rose
dramat
cohr
et
al
follow
acut
estrogen
withdraw
concentr
increas
hr
postwithdraw
determin
use
function
nucleas
assay
silverman
hplc
evid
gather
cours
studi
cohr
et
al
found
distinct
rrna
speci
nucleotid
length
underw
signific
increas
intens
hr
acut
estrogen
withdraw
rrnaderiv
fragment
show
ident
mobil
denatur
agaros
gel
rrna
fragment
produc
chick
oviduct
ribosom
incub
vitro
partial
purifi
rnase
chick
oviduct
cohr
et
al
conclud
chick
oviduct
rnase
may
involv
degrad
rrna
brought
estrogen
withdraw
rnase
may
play
role
normal
turnov
rrna
nonetheless
sinc
specif
rnasederiv
ovalbumin
mrna
product
could
detect
sinc
rrnaderiv
fragment
show
detect
increas
hr
estrogen
withdraw
ovalbumin
mrna
degrad
would
seem
prematur
implic
system
ovalbumin
mrna
turnov
orlic
et
al
discov
rat
bone
marrow
cell
cultur
inhibit
abil
respond
erythropoietin
induct
red
cell
format
treat
tetram
core
p
pa
p
concentr
tetram
core
caus
reduct
erythroid
coloni
also
inhibit
jh
thymidin
incorpor
orlic
et
al
found
liver
spleen
rat
made
anem
phenylhydrazin
inject
direct
correl
rate
erythropoiesi
synthetas
activ
studi
later
extend
orlit
et
al
orlit
et
al
mclude
hypoxiainduc
phenylhydrazineinduc
erythropoiesi
mice
latter
case
spleen
cell
lysat
show
increas
synthetas
activ
assay
poli
poy
g
aros
method
hypoxia
studi
synthetas
increas
control
valu
moreov
synthetas
activ
maxim
spleen
cell
popul
contain
largest
number
nucleat
cell
wherea
synthetas
activ
minim
popul
carri
fewest
nucleat
cell
addit
orlic
et
al
found
trimer
tetram
core
partial
inhibit
colonyform
respons
basi
forego
result
specul
advanc
may
play
role
regul
late
event
erythropoiesi
possibl
relev
observ
report
increas
synthetas
activ
due
induct
autocrin
ifn
sinc
treatment
cell
autocrin
ifn
produc
brought
increas
synthetas
ceil
g
phase
effect
cell
phase
cell
cycl
well
mallucci
mous
embryo
fibroblast
system
low
basal
level
synthetas
maintain
concurr
low
concentr
kb
synthetas
mrna
induct
cell
go
autocrin
ifn
caus
consider
increas
amount
kb
mrna
trace
appear
kb
synthetas
mrna
contrast
surg
phase
synthetas
activ
unrel
autocrin
ifn
relat
express
kb
synthetas
mrna
similar
result
obtain
ifn
employ
virusinduc
activ
attribut
higher
confluent
quiescent
gt
cell
contrast
report
rnase
l
activ
rose
phase
also
contrast
studi
well
mallucci
could
detect
signific
concentr
nm
cell
extract
hplc
conclud
involv
control
cell
cycl
mous
embryo
fibroblast
must
oper
subnanomolar
level
result
local
activ
activ
brief
period
time
cell
ifni
treatment
caus
inhibit
growth
prolong
phase
also
caus
dramat
morpholog
alter
includ
increas
cell
size
product
sheet
fuse
cell
kumar
mendelsohn
cell
synthetas
activ
increas
approxim
time
kb
mrna
addit
differenti
induct
express
differ
synthetas
isoenzym
well
appar
differ
enzym
activ
three
isoenzym
suggest
author
growth
inhibit
cell
ifn
involv
mediat
synthetas
second
studi
kumar
mendelsohn
found
cell
treat
ifni
specif
synthes
pdgf
mitogen
found
platelet
releas
blood
clot
reaction
wound
site
pdgf
probabl
mani
function
includ
promot
repair
damag
tissu
cooper
growth
factor
treatment
cell
pdgf
induc
state
compet
pledger
et
al
cell
respond
defin
growth
factor
insulinlik
growth
factor
epiderm
growth
factor
proceed
engag
dna
synthesi
varieti
compet
gene
describ
includ
cf
cmyc
cochran
et
al
zullo
et
al
found
dsrna
potent
induc
compet
gene
famili
convers
group
also
report
pdgf
stimul
express
gene
usual
character
dsrnainduc
name
synthetas
ifnp
zullo
et
al
propos
synthetas
ifn
gene
could
function
feedback
loop
control
cell
growth
specul
mitogeni
respons
pdgf
may
inher
selflimit
thu
time
induc
gene
necessari
trigger
cell
divis
pdgf
may
also
induc
gene
requir
eventu
control
divis
ethanol
also
induc
synthetas
mrna
activ
well
hsp
chelbialix
chousterman
contrast
forego
situat
heat
shock
chousterman
et
al
ethanol
also
induc
ifn
synthesi
antivir
state
mdbk
cell
chelbialix
chousterman
antivir
state
appear
synthetas
activ
could
prevent
antibodi
bovin
ifnp
therebi
establish
synthetas
induc
extern
ifn
hsp
thu
even
though
mechan
induct
synthetas
differ
chelbialix
chousterman
observ
cellular
recoveri
ethanol
treatment
may
involv
synthetas
case
heat
shock
oligonucleotid
might
serv
signal
termin
stress
respons
tubular
reticular
inclus
interferon
ifn
treatment
induc
format
cytoplasm
tubular
reticular
inclus
tri
complex
membran
tubul
associ
endoplasm
reticulum
perinuclear
cisterna
grimley
et
al
grimley
schaff
typic
observ
human
acquir
immunodefici
syndrom
aid
system
lupu
erythematosu
diseas
endogen
ifn
product
increas
rel
diseasefre
subject
feldman
et
al
note
human
umbil
vein
thorac
aorta
endotheli
cell
ifn
induc
format
tri
condit
wherein
synthetas
also
induc
howev
wherea
synthetas
activ
remain
constant
day
ifn
treatment
tri
continu
increas
size
number
correl
tri
synthetas
induct
also
fail
extend
number
cell
line
tri
form
even
though
signific
elev
synthetas
activ
found
mous
cell
condit
wherein
ifn
bring
increas
pkr
synthetas
predominantli
kda
isoenzym
addit
sarcolectin
hr
ifn
result
major
decreas
synthetas
pkr
judg
enzym
activ
western
blot
jiang
et
al
suggest
sarcolectin
may
induc
protein
oppos
equilibrium
fashion
format
two
uninduc
protein
pkr
synthetas
sinc
sarcolectin
oppos
ifn
action
possibl
could
part
homeostat
mechan
control
cell
growth
differenti
instanc
found
togeth
human
placenta
fetal
phase
pregnanc
cjrowth
inhibit
interferon
describ
human
epidermoid
cell
line
call
highli
sensit
growth
inhibitori
effect
wa
poli
poli
c
caus
secret
ifn
medium
cell
antiun
serum
block
growthinhibitori
effect
poli
poli
c
poli
poli
c
howev
produc
induct
synthetas
activ
increas
caus
deg
radat
prerrna
rna
nonetheless
could
found
poli
poli
c
treat
cell
extract
result
hypothes
due
high
activ
author
specul
growth
inhibitori
effect
dsrna
cell
independ
ifn
action
rather
associ
rrna
degrad
perhap
caus
activ
system
maor
et
al
p
rovid
first
viva
evid
synthetas
may
involv
differenti
process
specif
endochondr
ossif
embryon
mous
mandibular
condyl
synthetas
activ
significantli
lower
prolif
zone
condyl
matur
condylar
zone
cartilagespecif
protein
alreadi
form
neonat
condyl
synthetas
activ
highest
chondroprogenitor
zone
contain
prolifer
cell
differenti
condylar
cartilag
proper
express
cartilag
antigen
complet
activ
synthetas
decreas
significantli
also
note
system
predomin
product
assay
determin
synthetas
activ
trimer
author
conclud
least
sync
hetas
could
use
marker
differenti
develop
condyl
cartilag
neonat
mous
address
whether
ifninduc
enzym
may
involv
differenti
salzberg
et
al
birnbaum
et
al
work
primari
myoblast
embryon
tissu
cultur
cell
underw
fusion
multinucl
myotub
show
spontan
contract
express
antigen
specif
muscl
infect
rat
skelet
muscl
cell
cultur
moloney
msv
block
myotub
format
well
musclespecif
protein
myosin
light
creatin
kinas
acetylcholin
receptor
viral
gene
express
infect
cell
contrast
uninfect
cell
cultur
growthassoci
gene
cnyc
transcript
decreas
time
moloney
msvinfect
cultur
cmyc
rna
transcript
increas
time
examin
control
cultur
show
synthetas
activ
increas
day
seed
cell
decreas
howev
msvinfect
cultur
synthetas
activ
reduc
immedi
infect
show
substanti
increas
day
cultur
nontransform
viru
moloney
murin
leukemia
viru
show
kinet
synthetas
activ
control
cultur
thu
normal
transient
express
synthetas
activ
associ
muscl
cell
differenti
cultur
significantli
alter
cell
cultur
infect
msv
find
suggest
author
potenti
role
synthetas
myogenesi
birnbaum
et
al
went
suggest
sinc
msvtransform
cell
unusu
high
activ
synthetas
may
possibl
enzym
function
regul
cell
growth
longer
may
control
effect
transform
cell
model
system
use
attempt
understand
differenti
neuron
treatment
rat
pheochromocytoma
cell
line
ngf
saarma
cowork
found
increas
synthetas
activ
cell
treat
ngf
simultan
detect
decreas
activ
activ
addit
underw
approxim
lofold
increas
first
hour
ngf
treatment
author
suggest
chang
constitu
system
associ
ngfdepend
differenti
cell
phenotyp
revert
cell
line
harastransform
nih
cell
obtain
prolong
treatment
unab
cell
maintain
revert
nontumorigen
phenotyp
resist
transform
specif
oncogen
still
express
harusspecif
mrna
protein
product
even
passag
absenc
ifn
samid
et
al
rimoldi
et
al
found
revert
cell
express
elev
level
synthetas
activ
correspond
kb
mrna
level
consider
higher
normal
parent
cell
harastransform
nih
cell
revert
cell
show
function
result
enhanc
express
synthetas
resist
infect
mengoviru
either
normal
transform
nih
cell
endogen
product
ifn
mrna
ifnb
could
detect
revert
cell
demonstr
cell
constitut
produc
function
synthetas
absenc
endogen
ifn
product
author
conclud
result
suggest
relationship
synthetas
express
reestablish
growth
control
cell
possess
revert
nontumorigen
phenotyp
peripher
blood
lymphocyt
pbl
examin
presenc
synthetas
studi
report
bonnevienielsen
et
al
pbl
homogen
spraguedawley
rat
bb
autoimmun
rat
observ
high
basal
level
synthetas
activ
absenc
poli
poli
c
moreov
addit
poli
poli
c
mgml
need
caus
activ
synthetas
synthetas
activ
bb
rat
pbl
total
unaffect
addit
poli
poli
c
pbl
extract
dog
pig
sheep
human
compar
virtual
lack
synthetas
activ
absenc
dsrna
show
increas
activ
concentr
poli
poli
c
increas
addit
remark
aspect
studi
find
pbl
extract
bb
rat
gave
rise
put
dimer
chang
addit
increa
attribut
substanti
dilut
virusinfect
cell
uninfect
crypt
cell
thu
even
though
ifn
limit
increas
viru
titer
cultur
cell
induc
synthetas
could
prevent
cytopath
effect
viru
similar
situat
obtain
viva
sinc
synthetas
increas
could
detect
intestin
newborn
pig
respons
ifn
induct
viru
virusinduc
histolog
present
yet
cellular
destruct
proceed
sinc
base
result
dsrna
must
gener
suffici
amount
activ
synthetas
dsrnaactiv
pkr
pathway
must
also
ineffectu
coronaviru
infect
establish
presenc
function
rnase
l
system
would
interest
creasey
et
al
caveat
addit
direct
evid
would
provid
give
hypothesi
support
great
deal
interest
center
around
activ
system
hiv
infect
wu
et
al
immunolog
dysfunct
hiv
may
includ
aberr
product
cytokin
ifna
ifn
instanc
decreas
level
ifna
cultur
pbmc
patient
hivl
report
voth
et
al
patient
aid
ifni
level
may
increas
rossel
et
al
also
evid
rnase
l
activ
lymphocyt
aid
patient
absent
despit
high
level
carter
et
al
metabol
enzym
present
nuclear
matrix
see
tar
element
fuse
heterolog
rna
result
inhibit
rna
translat
ederi
et
al
sengupta
silverman
maitra
et
al
found
translat
inhibit
due
part
activ
ifninduc
pkr
hivl
leader
rna
contain
dsrna
stemloop
structur
addit
synthetas
also
activ
purifi
tar
rna
sengupta
silverman
maitra
et
al
although
postul
activ
ifninduc
enzym
could
play
role
inhibit
hiv
roy
cowork
report
thu
hiv
infect
would
act
mitig
potenti
translat
inhibitori
effect
tar
rna
mechan
involv
dsrna
protein
kinas
roy
et
al
cowork
report
nuclear
matrix
hivinfect
well
uninfect
human
tcell
contain
synthetas
increas
factor
ln
hivinfect
cell
report
baca
et
al
note
releas
hiv
delay
prevent
agent
maintain
high
intracellular
level
stimul
dsrnadepend
antivir
respons
infect
cell
exampl
ifn
ho
et
al
lectin
schroder
et
al
mismatch
dsrna
ampligen
carter
et
al
tramactiv
protein
tat
enhanc
ltrdirect
gene
express
bind
tar
rosen
present
hiv
ltr
well
hiv
transcript
tar
suffici
secondari
structur
bind
activ
synthetas
vitro
schroder
et
al
sengupta
silverman
howev
bind
synthetas
tar
vitro
prevent
addit
tat
preferenti
cleavag
hiv
mrna
may
occur
local
activ
synthetas
area
hiv
transcript
present
high
concentr
result
low
level
hiv
mrna
present
earli
stage
infect
therefor
treatment
prevent
tat
tar
bind
complex
metal
ion
requir
tat
dimer
may
restor
antivir
state
enabl
tar
becom
capabl
activ
synthetas
thu
product
strategi
treat
hiv
infect
use
system
may
includ
develop
dsrna
analogu
increas
product
nucleasest
phosphatasest
potent
analogu
et
al
diabet
system
sinc
potenti
associ
develop
autoimmun
diseas
type
diabet
viru
infect
report
rayfield
gambl
yoon
et
al
ginsbergfelln
et
al
sinc
fact
ifna
found
insulinsecret
pancreat
pcell
fouli
et
al
show
basal
level
synthetas
normal
control
show
increas
respons
ifn
compar
increas
synthetas
ifntreat
control
gerd
et
al
mani
ovin
porcin
caprin
speci
prostaglandin
respons
induc
regress
corpu
luteum
pregnanc
prostaglandin
continu
releas
mode
releas
chang
pulsatil
held
respons
regress
corpu
luteum
protein
factor
identifi
ovin
trophoblast
protein
bovin
trophoblast
protein
found
primarili
respons
alter
prostaglandin
secret
pattern
barro
et
al
moreov
btpi
character
ifn
close
relat
ena
ifnw
robert
similar
protein
describ
human
also
aboagyemathiesen
et
al
possess
antivir
activ
gill
therefor
unexpectedli
infus
caus
enhanc
synthetas
activ
endometrium
ewe
earli
pregnanc
conceptu
protein
induc
synthetas
activ
madindarbi
kidney
cell
ifna
p
addit
bifnol
induc
natur
defens
system
synthetas
activ
monolay
endometri
epitheli
stromal
cell
miranda
et
al
also
shown
presenc
c
f
bovin
conceptu
period
matern
recognit
pregnanc
caus
induct
synthetas
activ
probabl
conceptu
secret
relat
find
led
hypothesi
system
induct
synthetas
may
act
alter
prostaglandin
synthesi
releas
uterin
cell
system
may
play
vital
biolog
role
mainten
earli
pregnanc
system
might
specif
function
mechan
clear
especi
sinc
mechan
select
action
rnase
l
becom
appar
yet
clue
alreadi
may
extant
literatur
howev
intrigu
studi
hansen
et
al
document
combin
decreas
transcript
rate
increas
mrna
turnov
system
basi
target
mrna
destruct
method
deriv
coval
linkag
oligodeoxyribonucleotid
activ
rnase
l
rnase
lesiak
et
al
composit
nucleic
acid
xiao
et
al
antisens
domain
could
target
chimera
particular
mrna
sequenc
would
target
destruct
compon
would
provid
local
activ
latent
rnase
fig
presum
kind
chimer
molecul
also
could
possess
mechan
action
classic
antisens
reagent
ie
passiv
hybrid
arrest
possibl
rnase
h
degrad
approach
would
bring
play
potent
catalyt
action
latent
endonucleas
perhap
therebi
substanti
increas
potenc
antisens
approach
prototyp
chimera
consist
antisens
domain
made
oligo
dt
connect
linker
lesiak
et
al
johnston
torrenc
linker
element
use
join
antisens
rather
directli
join
abil
thu
novel
conjug
molecul
retain
abil
partner
construct
interact
relev
biolog
receptor
manner
consist
propos
mechan
action
strategi
sitedirect
rna
cleavag
first
evalu
rnase
enzym
respons
rna
destruct
technolog
extend
natur
mrna
demonstr
specif
destruct
intact
cell
target
mrna
chosen
code
protein
kinas
pkr
eninduc
protein
regul
protein
synthesi
function
tumor
suppressor
pkr
mrna
site
chosen
target
chimera
nucleotid
start
codon
pkr
mrna
basi
synthes
follow
antisens
chimer
molecul
direct
pkr
mrna
chimera
refer
pa
antipkr
moieti
antisens
sequenc
link
phosphodiest
bond
two
unit
turn
join
phosphodiest
bond
chimera
abl
effect
cleavag
p
label
pkr
mrna
cellfre
system
contain
purifi
human
recombin
rnase
observ
cleavag
detect
nm
pa
antipkr
nearli
complet
cleavag
occur
nm
condit
nm
sens
orient
chimera
requir
caus
cleavag
pkr
mrna
maitra
et
al
thu
cellfre
system
composit
molecul
potent
selec
recent
respiratori
syncyti
viru
rsv
replic
target
use
cirino
et
al
previou
trial
acyclovir
show
substant
clinic
improv
cf
patient
poli
poli
clzu
ampligen
evalu
potenti
therapeut
agent
suhadolnik
et
al
studi
conduct
patient
particularli
debilit
cf
poli
pli
c
u
given
patient
suhaldolnik
et
al
level
synthetas
rnase
l
measur
therapi
data
compar
healthi
untreat
control
cf
patient
significantli
lower
basal
level
latent
synthetas
p
oool
higher
level
higher
pretherapi
rnase
l
level
p
ooool
compar
control
pmbc
extract
also
higher
synthetas
level
control
pmbc
extract
test
posit
replic
poli
pli
cu
therapi
result
signific
decreas
activ
p
ool
decreas
rnase
l
activ
well
neuropsycholog
improv
whether
observ
relat
find
immun
ifn
tnf
inhibit
rrna
process
activ
rnase
l
remain
determin
increas
endoribonucleolyt
activ
well
increas
rnase
l
activ
observ
extract
pmbc
isol
patient
chronic
myelogen
leukemia
cml
hubbel
et
al
rrna
cleavag
assay
use
evalu
context
activ
two
differ
rrna
cleavag
product
could
observ
smallest
rrna
cleavag
product
gener
band
present
reduc
intens
importantli
band
label
affin
reaction
carri
presenc
excess
suggest
involv
specif
bind
kraus
et
al
st
laurent
et
al
wreschner
et
al
floydsmith
et
al
bisbal
et
al
instanc
certain
affinitylabel
product
disappear
proteas
inhibitor
includ
cell
extract
prepar
manipul
kraus
et
al
result
presum
might
explain
understand
rnase
l
dimer
cole
et
al
bayard
et
al
salehzada
et
al
associ
protein
bisbal
et
al
continu
emerg
consider
proteolyt
degrad
proteinprotein
associ
notwithstand
biolog
biochem
effect
close
relat
compound
report
instanc
castora
et
al
show
calf
thymu
type
dna
topoisomeras
inhibit
number
extent
inhibit
increas
degre
chain
length
thu
hexam
ppp
p
effect
reduc
relax
dna
topoisomeras
submicromolar
concentr
find
complet
corrobor
later
report
appar
anomali
system
product
synthetas
bind
activ
rnase
l
nonetheless
alarcon
et
al
report
inhibit
vsv
product
dimer
possibl
effect
earli
viru
transcript
subramanian
et
al
demonstr
inhibitor
purifi
rna
polymeras
nucleocapsid
complex
vsv
standard
assay
condit
inhibit
requir
approxim
p
dinucleotid
characterist
inhibit
reaction
significantli
differ
usual
associ
system
gener
requir
sinc
equal
effect
dimer
effect
higher
oligom
greatli
reduc
inhibitori
activ
dimer
triphosph
activ
dimer
nearli
devoid
activ
intermedi
inhibitori
potenc
possibl
relat
studi
tominaga
et
al
found
dimer
core
ad
cell
without
permeabl
treatment
could
inhibit
replic
sindbi
viru
vsv
inhibit
viral
protein
synthesi
phosphoryl
form
dimer
show
effect
difficult
see
connect
report
work
alarcon
et
al
subramanian
et
al
similar
vein
pivazian
et
al
report
dinucleotid
potent
noncompetit
inhibitor
poli
adpribos
transferas
activ
ki
pm
activ
longer
report
sobol
et
al
report
abil
variou
analogu
function
noncompetit
inhibitor
primerhivl
revers
transcriptas
complex
format
deriv
inhibitori
ki
approxim
fm
need
optimum
inhibit
rio
et
al
show
could
inhibit
rotaviru
vitro
transcript
inhibit
increas
chain
length
potenti
given
oligoadenyl
inhibit
appear
competit
appar
k
pm
also
inhibitori
hexamer
longer
chain
length
effect
surprisingli
vitro
rotaviru
replic
could
inhibit
show
hypochrom
greater
lead
suggest
degre
base
stack
greater
oligoadenyl
doombo
et
al
doombo
et
al
hand
compar
examin
versu
oligoadenyl
tetram
pentam
hexam
reveal
chang
extinct
coeffici
grow
chain
length
increas
remain
constant
congen
result
impli
stack
weaker
compar
dhingra
sarma
use
nmr
hand
schleich
et
al
note
larg
chemic
shift
differ
base
carbon
dimer
versu
monom
indic
base
stack
tool
raman
spectroscopi
white
et
al
conclud
littl
base
stack
trimer
contrast
weaver
william
found
raman
spectroscopi
stack
deoxi
trimer
studi
oligonucleotid
also
differ
conclus
regard
stack
interact
parthasarathi
cowork
conduct
xray
analys
dinucleotid
c
conclud
compact
righthand
helix
could
exist
crystal
stack
involv
intramolecular
ribos
stack
rather
classic
intramolecular
base
stack
dinucleotid
u
also
display
reduc
base
stack
compar
u
anoth
xray
crystallograph
studi
shefter
et
al
xray
studi
complex
enzym
rnase
base
stack
seen
dinucleotid
sinc
extend
structur
requir
optimrz
contact
enzym
activ
site
shefter
et
al
kondo
et
al
investig
cd
uv
nmr
paramet
associ
isomer
pair
well
c
c
author
note
comparison
base
stack
deriv
singl
physicochem
measur
necessarili
meaning
quit
mislead
found
base
cd
measur
order
base
stack
c
c
howev
uv
measur
base
stack
order
c
c
nmr
dimer
shift
base
stack
interact
c
c
adenin
proton
use
calcul
dimer
shift
contrast
adenin
use
basi
order
stack
kondo
cowork
went
develop
model
use
nmr
data
establish
rel
base
orient
spacefil
model
backbon
constraint
conclud
base
stack
interact
stronger
c
c
respect
warshaw
cantor
also
conclud
possess
signific
degre
base
stack
particularli
compel
comparison
sund
et
al
consist
differ
solut
studi
mostli
indic
stronger
tendenc
base
stack
compar
xray
crystallograph
studi
indic
littl
base
stack
ascrib
use
free
acid
nucleotid
form
ph
xray
studi
use
salt
form
ph
variou
solut
studi
parthasarathi
et
al
experiment
studi
accompani
sever
relev
theoret
calcul
may
provid
addit
understand
fundament
differ
dhingra
sarma
employ
empir
dimer
shift
collect
dinucleotid
gener
set
conform
paramet
describ
gener
dramat
outcom
find
glycosid
torsion
angl
x
first
residu
low
syn
domain
xl
glycosid
torsion
angl
second
residu
anti
domain
thu
glycosid
torsion
angl
first
nucleotid
syn
rang
contrast
anti
conform
found
second
residu
critic
possess
anti
conform
xz
end
result
determin
conform
paramet
use
repeat
mode
helix
format
could
obtain
backbon
torsion
angl
fix
glycosid
torsion
angl
allow
vari
could
helic
form
certain
domain
short
could
incorpor
helic
structur
valu
x
base
stack
interact
form
parthasarathi
et
al
found
overal
conform
base
xray
diffract
analysi
c
markedli
differ
sinc
orient
backbon
inward
toward
base
rather
away
base
oligo
use
conform
paramet
determin
c
parthasarathi
colleagu
determin
possibl
helic
might
built
compact
singlestrand
poli
c
h
e
could
gener
readili
character
righthand
helix
four
base
per
helic
turn
altern
purin
pyrimidin
repeat
unit
dinucleotid
gpcp
cpgp
purin
syn
conform
pyrimidin
anti
conform
base
stack
minim
gpc
moieti
stack
import
howev
cpg
moieti
base
stack
c
g
cpg
fragment
differ
conform
z
dna
attempt
build
doubl
helix
linkag
fail
order
keep
residu
stack
watsoncrick
hydrogenbond
site
point
opposit
direct
anukanth
ponnuswami
perform
exhaust
theoret
calcul
analysi
probabl
conform
result
conform
within
kcalmol
global
minimum
energi
state
result
anukanth
ponnuswami
abl
gener
doublehel
structur
similar
backbon
torsion
angl
standard
b
doubl
helic
howev
base
stack
may
minim
model
srinivasan
olson
calcul
indic
long
helic
form
although
short
miniduplex
possibl
adjac
base
stack
result
mix
glycosyl
angl
sugar
pucker
backbon
data
impli
possibl
altem
aand
btype
stack
pattern
experiment
solid
phase
support
synthesi
oligoribonucleotid
demonstr
complementari
sequenc
form
complex
antiparallel
watsoncrick
hydrogen
bond
strand
albeit
significantli
lower
analogu
kierzek
et
al
thu
selfcomplementari
cggcgccg
possess
c
wherea
condit
sequenc
c
giannari
damha
report
oligoribonucleotid
exhibit
remark
specif
ssrna
instanc
cccucucccuucu
form
duplex
oligom
agaagggagaggg
salt
ph
detect
complex
format
observ
correspond
dna
oligom
agaagggagaggg
form
complex
triplex
poli
u
c
wherea
correspond
complex
poli
dt
nacl
complex
poli
dt
observ
concentr
nacl
giannari
damha
also
observ
complex
format
display
nacl
compar
correspond
duplex
recent
flurri
public
dna
linkag
dougherti
et
al
hashimoto
switzer
jin
et
al
jung
switzer
alul
hoke
robinson
et
al
sheppard
breslow
although
initi
report
use
confus
brid
select
togeth
enhanc
nucleas
resist
led
suggest
may
find
use
antisens
applic
detail
compar
studi
use
nmr
model
build
van
den
hoogen
et
al
explor
conform
facet
trimer
seri
analogu
substitut
bfia
first
residu
second
residu
caus
shift
ns
sugar
conform
equilibrium
slight
prefer
n
first
second
residu
strong
n
prefer
moreov
shift
strong
prefer
n
present
albeit
less
magnitud
bromin
analogu
regardless
whether
residu
bromin
instanc
mole
percent
n
shift
n
still
shift
b
contrast
bromin
third
residu
led
strong
prefer
stype
sugar
conform
wherea
prefer
seen
third
unmodifi
bromin
residu
led
greater
eclips
ribos
flatter
ribos
ring
bromin
residu
al
also
led
syn
orient
base
residu
residu
pa
bbromin
base
syn
conform
favor
togeth
sugar
conform
glycosid
conform
contrast
strongli
sugarbas
torsion
angl
anti
rang
variat
glycosid
torsion
angl
led
differ
stack
interact
compar
variou
bromin
analogu
relat
investig
xylofuranosyl
adenin
contain
oligoadenyl
trimer
van
den
boogaart
et
al
found
fluorin
substitu
xylo
ntype
sugar
conform
favor
flatten
ribos
ring
syn
orient
base
xylofluorosubstitut
residu
fluorin
ribo
posit
adenosinesubstitut
analogu
sugar
conform
substitut
residu
nearli
pure
stype
ribos
fluorin
littl
effect
conform
paramet
discoveri
ribozym
kruger
et
al
guerriertakada
et
al
rekindl
earlier
specul
woes
orgel
crick
rna
replic
preced
protein
synthesi
evolut
rna
world
gilbert
pace
marsh
sharp
lewin
gesteland
atkin
jame
ellington
lazcano
miller
encompass
idea
earli
epoch
evolut
rna
replic
respons
transfer
gene
one
gener
next
watsoncrick
basepair
oper
recognit
mode
base
catalyt
rna
protein
specifi
rna
gene
prebiot
viewpoint
assembl
bondlink
oligonucleotid
implaus
event
unless
intervent
appropri
catalyst
postul
would
increas
percentag
format
usher
point
fact
lead
ioncatalyz
uranyl
ioncatalyz
oligomer
activ
nucleotid
nucleosid
give
rise
predominantli
oligonucleotid
sleeper
orgel
sawai
et
al
stick
point
chemic
evolut
rna
larg
bypass
prebiot
field
postul
yet
unfound
metal
ion
acidbas
catalyst
specif
miner
surfac
nucleotid
precursor
might
adsorb
result
product
desir
gesteland
atkin
even
condit
templatedirect
synthesi
bond
format
favor
except
select
condit
joyc
inou
orgel
knotti
problem
propens
format
bond
address
usher
studi
rel
rate
hydrolysi
two
oligoadenyl
name
th
e
differ
two
oligoadenyl
replac
singl
bond
bond
equival
hydrolyt
rate
alkalin
condit
remark
howev
addit
u
individu
oligonucleotid
led
dramat
differ
alkalin
hydrolysi
rate
oligonucleotid
singl
hydrolyz
much
rapidli
led
usher
conclus
linkag
time
less
stabl
bond
usher
ration
differ
consider
mechan
hydrolysi
nucleotid
diester
usher
mchale
doublehel
rna
contain
hydrolysi
intramolecular
attack
phosphoru
would
involv
leav
energet
less
favor
adjac
westheim
ie
inclus
singl
bond
oligonucleotid
rate
hydrolysi
complex
either
rna
rna
matter
studi
carri
rel
rate
hydrolysi
bond
oligonucleotid
complex
complementari
oligonucleotid
rel
behavior
situat
data
avail
remain
prematur
draw
conclus
rel
stabil
bond
describ
earlier
review
section
rna
gener
seem
form
less
stabl
associ
complementari
thu
would
expect
time
base
duplex
stabil
properti
alon
would
select
basi
selfrepl
rna
system
phosphodiesterlink
nucleic
acid
found
natur
probabl
best
known
bond
form
lariat
rna
intermedi
gene
splice
voet
voet
linkag
also
form
peculiar
satellit
dna
call
multicopi
singlestrand
dna
sun
et
al
multicopi
singlestrand
dna
made
singlestrand
dna
link
rna
bond
guanosin
nucleotid
residu
rna
laurenc
et
al
use
highli
specif
monoclon
antibodi
oligonucleotid
demonstr
presenc
dimer
pentamer
varieti
mammalian
tissu
even
remark
bacteria
yeast
origin
function
adeni
late
latter
remain
unknown
exampl
notwithstand
remain
exampl
nucleic
acid
contain
one
tandem
spite
readi
testtub
abil
synthetas
add
adenyl
substrat
add
nucleotid
relic
bygon
rna
world
synthetas
rnase
l
found
simpler
life
form
bacteria
fungi
mold
yeast
amphibian
insect
cayley
et
al
report
kuusksalu
et
al
function
activ
synthetas
marin
spong
suggest
entir
question
presenc
system
primit
anim
revisit
might
simpli
later
evolutionari
adapt
may
possibl
eventu
determin
role
molecul
play
enzym
action
rnase
l
may
provid
answer
specif
molecul
actual
particip
catalyt
reaction
cleavag
prefer
rnase
l
upnp
sequenc
relat
hydrogen
bond
interact
substrat
recognit
process
floydsmith
et
al
system
uniqu
power
regulatori
system
thu
dsrna
stimul
uniqu
enzym
synthes
small
novel
oligonucleotid
turn
activ
uniqu
nucleas
rnase
l
insofar
decay
mrna
cardin
import
posttranscript
regul
gene
express
influenc
varieti
environment
development
factor
belasco
brawerman
seem
clear
potenti
role
system
could
widespread
inde
past
research
field
broach
larg
number
arena
role
system
posit
nonetheless
gener
accept
role
system
date
one
mediat
antipicornaviru
effect
ifn
research
next
decad
like
reveal
answer
mani
question
pose
year
sinc
discov
instanc
major
advanc
may
expect
understand
key
enzym
rnase
l
complet
pictur
act
turn
nucleas
certainli
obtain
pure
enzym
access
intrigu
question
whether
rnase
l
andor
lesson
teach
us
eventu
adapt
benefit
human
medicin
would
bring
stori
full
circl
ifn
therapeut
base
one
aspect
ifn
action
question
remain
whether
twoedg
sword
shape
delic
scalpel
synthetas
mrna
interleukin
differenti
murin
myeloid
cell
cytokin
birnbaum
trink
b
shainberg
salzberg
activ
interferon
system
myogenesi
vitro
